Benchmark Botanics Inc through its subsidiaries, operates as a producer of medical cannabis. The company provides financing, partnership opportunities and acquisition offers to licensed producers and ancillary businesses within the cannabis industry. It operates approximately 12,000 square foot production facility in Peachland, British Columbia.

BENCHMARK BOTANICS INCORD by Benchmark Botanics Inc.

Benchmark Botanics

Atai Life Sciences (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/atai#NASDAQ">ATAI</a>), a biotech company in the psychedelic space, had its Nasdaq debut on Friday.
The Berlin-based company is joining an exclusive group of start-ups in the psychedelics sector to IPO this year at Nasdaq, including MindMed (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/mnmd#NASDAQ">MNMD</a>) and Compass Pathways (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/cmps#NASDAQ">CMPS</a>).
Initially founded as a holding group that later became involved in operations, Atai handles a growing portfolio of about 12 companies, all focused on bringing novel mental health treatments through the use of various disruptive technologies and molecules including psychedelic medicines.
Its portfolio includes Perception Neurosciences, a company putting ketamine through clinical trials for the treatment of depression, as well as other companies developing psychedelics like&nbsp; MDMA, ibogaine and DMT for mental health purposes.
Atai is also a major shareholder in Compass Pathways, a company developing psilocybin products for psychedelics-assisted psychotherapy, which was the first psychedelics company to <a href="https://www.benzinga.com/markets/cannabis/20/09/17571756/mind-medicine-ceo-calls-compass-ipo-a-clear-bellwether-for-psychedelic-space">debut on Wall Street in September 2020</a>.
Largely focused on drug development, Atai&rsquo;s revenue stream is still dependent on the regulatory approval of the compounds and treatments in its pipeline. As of now, molecules and treatments under Atai&rsquo;s wing are still going through different stages of development from discovery to Phase II clinical trials.
Backed by PayPal (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/pypl#NASDAQ">PYPL</a>) founder Peter Thiel, the company had raised over $362 million since its inception in 2018. Atai raised an additional $225 million from its upsized initial public offering on Thursday, selling 15 million shares at a price of $15.
Price Action: Atai stock opened trading at $21, giving the company&nbsp;a market valuation of about $3.19 billion.
The stock peaked at about $22 before noon&nbsp;and reached a low-end point of $16.50 to close its first day of trading at $19.45.
Photo by lo lo on Unsplash

Cannabis

Penny Stocks

Small Cap

Markets

ATAI

CMPS

MNMD

PYPL

Peter Thiel-backed Psychedelics Company Rings Nasdaq Bell: Atai Life Sciences Goes Public

The highly anticipated 2020 Summer Olympics in Tokyo are set to premiere in July after a COVID-19 related delay.
The Summer Olympics could mean big money for NBC and its parent company Comcast Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/cmcsa#NASDAQ">CMCSA</a>).
What Happened: At a recent <a href="https://www.bloomberg.com/news/articles/2021-06-14/nbc-says-olympics-may-be-most-profitable-ever-despite-pandemic?sref=TBDibEcD">presentation</a>, NBC said the upcoming 2020 Summer Olympics (July 23 to Aug. 8)&nbsp;could be the most profitable for the company.
&ldquo;Depending on how ratings are, it could be our most profitable Olympics in the history of the company, NBCUniversal CEO Jeff Shell said.
Prior to the pandemic, the company had sold $1.25 billion in advertisements, seeing strong demand from many sectors. The interest&nbsp;is due to many of the U.S. Olympians favored in their events and sports, which could help with strong viewership.
NBC plans more than&nbsp;7,000 hours of programming for broadcast, cable and its Peacock streaming platform.
The Peacock streaming platform for NBC will also <a href="https://variety.com/2021/tv/news/peacock-docuseries-female-olympians-96-games-1234997372/">launch </a>coverage of some of the best female Olympians from the 1996 Summer Olympics. This includes &ldquo;The &rsquo;96 Effect,&rdquo; a three-part docuseries following women who won gold medals.
Peacock will also stream the U.S. Women&rsquo;s National Soccer Team final game, which has never been televised, alongside &ldquo;The Sisters of &rsquo;96: The 1996 USA Women&rsquo;s Soccer Olympic Team,&rdquo; which will reunite some of the soccer stars to watch the match together.
Related Link:<a href="https://www.benzinga.com/news/21/03/20079372/why-comcast-could-be-ready-to-cash-in-on-hulu-stake-with-disney"> Why Comcast Could Be Ready To Cash In On Hulu Stake With Disney</a>
Why It&rsquo;s Important:&nbsp;NBC <a href="https://nbcsportsgrouppressbox.com/2016/08/22/nbcs-rio-olympics-is-the-most-successful-media-event-in-history/">called </a>the 2016 Summer Olympics the most successful media event in history with $250 million in profit for the company.&nbsp;
An average of 27.5 million people tuned into Primetime Olympics coverage in 2016, representing the second-highest primetime audience for any non-U.S. Summer Olympics. Records were set for the 18 to 34 and 18 to 49 adult demographics in 2016. Seventy-eight percent of U.S. homes tuned into NBC for Olympics coverage in 2016.
The inclusion of Olympics coverage on cable networks owned by Comcast also boosted their viewership, including NBCSN being the No. 1 sports cable network for primetime viewers over a 14-day period during the Olympics.
Comcast paid $4.4 billion for the U.S. rights to the Olympics from 2014 to 2020, representing around $1.1 billion per Olympics. The company&rsquo;s renewal for the Olympics rights from 2021 to 2032 was for $7.75 billion, representing $1.3 billion per Olympics.
The 2016 Olympics coverage from Comcast featured 6,755 hours of content, which is expected to be passed this year and could help viewer figures.
While the 2020 Summer Olympics will be missing several high-profile athletes such as&nbsp;Michael Phelps and Usain Bolt, it could see strong viewership for returning athletes like Simone Biles, Katie Ledecky and others.
&ldquo;Simone Biles is just amazing. She&rsquo;s going to be on every night and then our swimming team is really strong and our track and field team is really strong,&rdquo; Shell said.
The results from the Olympics along with the guidance of advertising demand could be keys&nbsp;to watch when Comcast reports second-quarter earnings in July and third-quarter results in October.
CMCSA Price Action: Shares of Comcast are down 1.41% to $56.71&nbsp;on Friday. Shares have traded between $37.77 and $59.11 over the last 52 weeks.
(Photo: Olympic Games)
&nbsp;

News

Sports

Global

Trading Ideas

General

CMCSA

Could The 2020 Olympics See Record Profits For Comcast?

<h3>GAINERS:</h3>
<ul>
<li><a href="https://quotes.benzinga.com/quote/CURR" target="_blank">CURE Pharmaceutical Hldg</a>&nbsp;(OTC: <a class="ticker" href="https://www.benzinga.com/stock/curr#OTC">CURR</a>) shares closed up 11.45% at $0.73</li>
<li><a href="https://quotes.benzinga.com/quote/MRMD" target="_blank">MariMed</a>&nbsp;(OTC: <a class="ticker" href="https://www.benzinga.com/stock/mrmd#OTC">MRMD</a>) shares closed up 9.23% at $1.06</li>
<li><a href="https://quotes.benzinga.com/quote/KSHB" target="_blank">KushCo Holdings</a>&nbsp;(OTC: <a class="ticker" href="https://www.benzinga.com/stock/kshb#OTC">KSHB</a>) shares closed up 6.56% at $0.92</li>
<li><a href="https://quotes.benzinga.com/quote/TBPMF" target="_blank">Tetra Bio Pharma</a>&nbsp;(OTC: <a class="ticker" href="https://www.benzinga.com/stock/tbpmf#OTC">TBPMF</a>) shares closed up 5.85% at $0.28</li>
<li><a href="https://quotes.benzinga.com/quote/UGRO" target="_blank">Urban-gro</a>&nbsp;(NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ugro#NASDAQ">UGRO</a>) shares closed up 4.53% at $9.70</li>
<li><a href="https://quotes.benzinga.com/quote/BLOZF" target="_blank">Cannabix Technologies</a>&nbsp;(OTC: <a class="ticker" href="https://www.benzinga.com/stock/blozf#OTC">BLOZF</a>) shares closed up 3.53% at $0.88</li>
<li><a href="https://quotes.benzinga.com/quote/TRSSF" target="_blank">TerrAscend</a>&nbsp;(OTC:&nbsp;<a class="ticker" href="https://www.benzinga.com/stock/trssf#OTC">TRSSF</a>) shares closed up 2.57% at $10.39</li>
</ul>
<h3>LOSERS:</h3>
<ul>
<li><a href="https://quotes.benzinga.com/quote/YCBD" target="_blank">cbdMd. Inc.</a>&nbsp;(AMEX:YCBD) shares closed down&nbsp;9.39% at $2.87</li>
<li><a href="https://quotes.benzinga.com/quote/BMMJ" target="_blank">Body and Mind</a>&nbsp;(OTC: <a class="ticker" href="https://www.benzinga.com/stock/bmmj#OTC">BMMJ</a>) shares closed down 7.39% at $0.32</li>
<li><a href="https://quotes.benzinga.com/quote/IVITF" target="_blank">Invictus MD Strategies</a>&nbsp;(OTC: <a class="ticker" href="https://www.benzinga.com/stock/ivitf#OTC">IVITF</a>) shares closed down 7.63% at $0.05</li>
<li><a href="https://quotes.benzinga.com/quote/ICNAF" target="_blank">Icanic Brands</a>&nbsp;(OTC: <a class="ticker" href="https://www.benzinga.com/stock/icnaf#OTC">ICNAF</a>) shares closed down 6.69% at $0.25</li>
<li><a href="https://quotes.benzinga.com/quote/MMNFF" target="_blank">MedMen Enterprises</a>&nbsp;(OTC: <a class="ticker" href="https://www.benzinga.com/stock/mmnff#OTC">MMNFF</a>) shares closed down 6.23% at $0.26</li>
<li><a href="https://quotes.benzinga.com/quote/CNVCF" target="_blank">BioHarvest Sciences</a>&nbsp;(OTC: <a class="ticker" href="https://www.benzinga.com/stock/cnvcf#OTC">CNVCF</a>) shares closed down 5.61% at $0.26</li>
<li><a href="https://quotes.benzinga.com/quote/VFF" target="_blank">Village Farms Intl</a>&nbsp;(NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/vff#NASDAQ">VFF</a>) shares closed down 4.95% at $9.99</li>
<li><a href="https://quotes.benzinga.com/quote/OGI" target="_blank">OrganiGram Holdings</a>&nbsp;(NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ogi#NASDAQ">OGI</a>) shares closed down 4.28% at $2.91</li>
</ul>
<a href="https://www.benzinga.com/cannabis/stocks/">Check out a full list of cannabis stock movers in real-time following this link.</a>
Lead image by Ilona Szentivanyi. Copyright: Benzinga.

After-Hours Center

BLOZF

BMMJ

CNVCF

CURE PHARMA HLDG CORP by CURE Pharmaceutical Holding Corp.

CURR

ICNAF

IVITF

KSHB

MMNFF

MRMD

TETRA BIO-PHARMA INC ORD by Tetra Bio-Pharma Inc.

TBPMF

TRSSF

UGRO

Cannabis Stock Gainers And Losers From June 18, 2021

Power tool company&nbsp;Stanley Black &amp; Decker Inc&nbsp;(NYSE: <a class="ticker" href="https://www.benzinga.com/stock/swk#NYSE">SWK</a>) CFO Donald Allan Jr is seeking partnerships with battery and chip manufacturers to ease the pressure on the tool maker&rsquo;s supply chain, the&nbsp;<a class="editor-rtfLink" href="https://www.wsj.com/articles/stanley-black-decker-cfo-looking-for-partnerships-with-battery-chip-makers-11624017600?mod=tech_lead_pos3" style="color:#4a6ee0; background:transparent; margin-top:0pt; margin-bottom:0pt" target="_blank">Wall Street Journal reports</a>.
What Happened:&nbsp;The company is seeking electric battery and computer chip makers for component supply in return for an investment.
Stanley Black &amp; Decker has a tentative partnership with a South Korean battery maker for a production line that will start manufacturing batteries in Malaysia in 2022. It is also in talks with other Asian and U.S. businesses about potential partnerships.
Stanley Black &amp; Decker estimated $500 million in 2021 capital expenditures. It plans to incur about 10% - 15% of that to supply-chain partnerships and other related initiatives. Supply chain partnerships accounted for less than 5% of the CAPEX before the pandemic.
Stanley Black &amp; Decker already has small-scale partnerships with companies that build specific tooling and production lines.
The company needs batteries for its cordless power tools and uses computer chips across its portfolio. It manufactures a significant portion of its products in the U.S. and Europe. It prefers to set up new production lines in those regions to beat Asia&rsquo;s long wait times.
Why It Matters:&nbsp;SWK remains bullish on demand for its components like batteries and chips.
Competitors like Japan&rsquo;s&nbsp;Makita Corp&nbsp;(OTC:&nbsp;<a class="editor-rtfLink" href="https://www.benzinga.com/stock/mktay#OTC" style="color:#4a6ee0; background:transparent; margin-top:0pt; margin-bottom:0pt" target="_blank">MKTAY</a>) and Hong Kong&rsquo;s&nbsp;Techtronic Industries Co Ltd&nbsp;(OTC:&nbsp;<a class="editor-rtfLink" href="https://www.benzinga.com/stock/ttndy#OTC" style="color:#4a6ee0; background:transparent; margin-top:0pt; margin-bottom:0pt" target="_blank">TTNDY</a>) manufacture a more significant chunk of their products in Asia, potentially providing them with easier access to batteries and chips.
Stanley Black &amp; Decker identified around critical 30 suppliers and extended and prolonged contracts with many of them for up to five years.
Any price hike for batteries and chips can have a sizable impact on its finances as the components account for the most significant proportion of goods sold.
The company raised the cost guidance from $160 million to $235 million for 2021 due to inflation. It aims to pass two-thirds of the increase on to customers and offset the rest by increasing efficiency and cost savings.
Stanley Black &amp; Decker began raising prices for some of its products this quarter and has more hikes due.
The company expects to free up between $100 million and $150 million a year by increasing efficiency and cost savings.
Stanley Black &amp; Decker&rsquo;s Q1 operating margin expanded 810 basis points to 16.9%.
The company will need more batteries&nbsp;<a class="editor-rtfLink" href="https://ir.stanleyblackanddecker.com/news-releases/news-release-details/stanley-black-decker-reaffirms-2021-guidance-and-provides" style="color:#4a6ee0; background:transparent; margin-top:0pt; margin-bottom:0pt" target="_blank">as it seeks to acquire the</a>&nbsp;remaining 80% of MTD Products Inc. MTD produces mowers and other outdoor equipment and expects to move toward using more electric motors in the coming years.
Price action:&nbsp;SWK shares closed lower by 0.25% at $194.92 on Friday.

Tech

Media

MKTAY

TTNDY

Stanley Black & Decker CFO Explores Battery, Chip Maker Partnerships To Ease Post Pandemic Supply Chain Pressure: WSJ

Earnings

Financing

AQSP

CCHWF

CLVR

CNBS

CRON

FFLWF

FLOOF

HEXO

HYFM

MAPS

MSOS

NFLX

PCLOF

SHWZ

SSPK

STMH

THCX

YOLO

The Week In Cannabis: Federal Drug Decrim, Connecticut, Louisiana, Big M&A Moves And More

Ammo Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/poww#NASDAQ">POWW</a>) shares were trading higher Friday as retail traders pushed the stock higher.
The stock looks to be breaking out, and was also trending on social media sites such as StockTwits Friday afternoon. Ammo Inc. trades with a 17-millio-share&nbsp;float, which is slightly lower than average, meaning the stock may be subject to quick movements.
Ammo Inc. gained 7.32% Friday, closing at $7.92.&nbsp;<img alt="powwdaily6-18-21.png" src="https://www.benzinga.com/files/u285825/powwdaily6-18-21.png" style="height:400px; width:640px" />
<h3>Ammo Inc. Daily Chart Analysis</h3>
<ul>
<li>Shares look to have broken out of what technical traders&nbsp;call a pennant pattern. The stock broke above pattern resistance and shares have headed higher.</li>
<li>The stock is trading above both the 50-day moving average (green), and the 200-day moving average (blue), indicating sentiment in the stock is bullish.</li>
<li>Each of these moving averages may hold as an area of support in the future.</li>
</ul>
<h3>Key Ammo Inc. Levels To Watch</h3>
<ul>
<li>Shares looked to have broken out of the pennant pattern after they crossed above the pattern resistance. Shares could see continued momentum if volume in the stock continues rising.</li>
<li>The pennant pattern happens after the stock makes a run up and the price is later condensed between the highs and lows until the price is able to break out of either support or resistance. Typically the stock continues momentum in the same direction as the break.</li>
<li>The Relative Strength Index (RSI) shows that the stock has been becoming more overbought throughout the past couple weeks. This means more buyers are entering into the stock and there are less sellers selling the stock. The stock may reach the overbought range if it is able to reach 70 on the RSI. The stock currently sits at 63 on the RSI.</li>
</ul>
<h3>What&rsquo;s Next For Ammo Inc.?</h3>
Bullish technical traders would like to see the stock continue to rise and stay above 50 on the RSI. Bears would like to see the stock continue to form higher lows and stay above the pattern support. If volume continues to come into the stock at the rate it is, now it could move higher.
Bearish technical traders would like to see the stock fall back into the pennant pattern&nbsp;and then drop below the pattern support. If this were to happen, the stock may change trends and see a downward push. Bears would also like to see the stock fall below 50 on the RSI.

Long Ideas

Short Ideas

Technicals

Movers

POWW

Ammo Stock Looks Like It May Be Breaking Out: What's Next?

<ul>
<li>Chinese government agents, including the antitrust watchdog, the cyber police, and tax authorities paid surprise visits to multiple domestic internet companies, including Didi Chuxing Technology Co, to check on possible antitrust violations, the&nbsp;<a class="editor-rtfLink" href="https://www.wsj.com/articles/china-steps-up-antitrust-inspections-of-internet-firms-11623943689?mod=tech_lead_pos3" style="color:#4a6ee0; background:transparent; margin-top:0pt; margin-bottom:0pt" target="_blank">Wall Street Journal reported</a>.</li>
<li>The agencies, including the State Administration for Market Regulation, the Cyberspace Administration of China, and the State Tax Administration agents, have grilled senior executives, downloaded contracts, financial records, and collected emails, internal communications.</li>
<li>These actions are a part of a regulatory review that followed submissions of self-examinations by 34 technology companies summoned in April.</li>
<li>The antitrust watchdog held another meeting with provincial-level regulators and asked them to follow up on the investigations in May.</li>
<li>The 34 companies included short-video app operator Bytedance Ltd, food-delivery firm&nbsp;Meituan&nbsp;(OTC: <a class="ticker" href="https://www.benzinga.com/stock/mpngf#OTC">MPNGF</a>) (OTC: <a class="ticker" href="https://www.benzinga.com/stock/mpngy#OTC">MPNGY</a>), and&nbsp;<a class="editor-rtfLink" href="https://www.benzinga.com/news/21/04/20855130/after-alibaba-tencent-set-to-face-antitrust-fine-in-china-report" style="color:#4a6ee0; background:transparent; margin-top:0pt; margin-bottom:0pt" target="_blank">social media company</a>&nbsp;Tencent Holdings Ltd&nbsp;(OTC: <a class="ticker" href="https://www.benzinga.com/stock/tcehy#OTC">TCEHY</a>).</li>
<li>The State Administration for Market Regulation senior official harped the importance of antimonopoly law enforcement for ensuring fair competition.</li>
<li>In 2020, the Chinese government&nbsp;<a class="editor-rtfLink" href="https://www.benzinga.com/fintech/20/11/18566955/jack-mas-ant-ipo-unlikely-to-happen-before-2022-over-new-regulatory-hurdles-report" style="color:#4a6ee0; background:transparent; margin-top:0pt; margin-bottom:0pt" target="_blank">canceled financial-technology</a>&nbsp;firm Ant Group Co.&rsquo;s initial public offering days after its controlling shareholder, Jack Ma&rsquo;s speech enraged government leaders and regulators.</li>
<li>Last week, Didi&rsquo;s IPO prospectus disclosed the completion of the regulator-mandated self-inspection and regulators&rsquo; on-site inspections.</li>
<li>China&rsquo;s anti-competitive practice crackdown on influential internet firms began in late 2020. In&nbsp;<a class="editor-rtfLink" href="https://www.benzinga.com/news/21/04/20568010/why-alibaba-just-got-hit-with-a-record-2-87-billion-fine-in-china?utm_source=dlvr.it&amp;utm_medium=facebook" style="color:#4a6ee0; background:transparent; margin-top:0pt; margin-bottom:0pt" target="_blank">April, China penalized</a>&nbsp;Alibaba Group Holding Ltd&nbsp;(NYSE: <a class="ticker" href="https://www.benzinga.com/stock/baba#NYSE">BABA</a>) by $2.8 billion following an antitrust probe. Recently, the crackdown has broadened to data privacy violations as well.</li>
<li>Price action:&nbsp;BABA shares closed higher by 0.29% at $212.30 on Friday.</li>
</ul>

Government

Regulations

BABA

MPNGF

MPNGY

TCEHY

China Ramps Antitrust Scrutiny On National Internet Firms: WSJ

Boeing&#39;s (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BA#NYSE">BA</a>) 737-10, the largest airplane in the 737 MAX family, today completed a successful first flight. The airplane took off from&nbsp;Renton Field&nbsp;in&nbsp;Renton, Washington, at&nbsp;10:07 a.m.&nbsp;and landed&nbsp;at&nbsp;12:38 p.m. at Boeing Field in&nbsp;Seattle.
&quot;The airplane performed beautifully,&quot; said 737 Chief Pilot Capt.&nbsp;Jennifer Henderson. &quot;The profile we flew allowed us to test the airplane&#39;s systems, flight controls and handling qualities, all of which checked out exactly as we expected.&quot;
Today&#39;s flight was the start of a comprehensive test program for the 737-10. Boeing will work closely with regulators to certify the airplane prior to its scheduled entry into service in 2023.
&quot;The 737-10 is an important part of our customers&#39; fleet plans, giving them more capacity, greater fuel efficiency and the best per-seat economics of any single-aisle airplane,&quot; said&nbsp;Stan Deal, president and CEO of Boeing Commercial Airplanes. &quot;Our team is committed to delivering an airplane with the highest quality and reliability.&quot;
The 737-10 can carry up to 230 passengers. It also incorporates environmental improvements, cutting carbon emissions by&nbsp;14 percent&nbsp;and reducing noise by&nbsp;50 percent&nbsp;compared to today&#39;s Next-Generation 737s.
As a leading global aerospace company, Boeing develops, manufactures and services commercial airplanes, defense products and space systems for customers in more than 150 countries. As a top U.S. exporter, the company leverages the talents of a global supplier base to advance economic opportunity, sustainability and community impact. Boeing&#39;s diverse team is committed to innovating for the future and living the company&#39;s core values of safety, quality and integrity. Learn more at&nbsp;<a href="https://c212.net/c/link/?t=0&amp;l=en&amp;o=3201726-1&amp;h=2923805300&amp;u=http%3A%2F%2Fwww.boeing.com%2F&amp;a=www.boeing.com" target="_blank">www.boeing.com</a>.

Boeing Completes Successful 737-10 First Flight

Pyxis Tankers Reports Receipt Of Nasdaq Notice Related To Minimum Bid Price Of $1/Share; Co. Has Til Dec. 13, 2021 To Regain Compliance

The ordering frenzy for new trailers came to an abrupt halt in May as fleets heeded manufacturers' pleas to avoid placing bookings they could not build. 

But boy, wait 'til next year.

"The market is in a strange place right now in that the bucket for 2021 orders is almost full, but the bucket in 2022 is essentially empty," said Don Ake, FTR Transportation Intelligence vice president of commercial vehicles. "We expect abnormally low activity until the 2022 order boards are opened. At that point, orders should shoot back up to near-record levels.

Net trailer orders in May totaled 8,676 units, down nearly 40% from April but more than 165% higher compared to the COVID-impacted May of 2020, according to ACT Research. 

FTR pegged final net trailer orders at 9,500 units, 42% below April. Year-over-year comparisons were up 112%. The rolling 12-month number for trailer orders stood at 368,000.

<h2 id="h-pausing-orders">Pausing Orders</h2>

Trailer manufacturers paused accepting orders after the backlog grew to nine to 11 months from order to delivery. Like many manufacturing businesses, trailer makers are struggling to find workers after shedding headcount during the early months of the pandemic in 2020.

"Getting people back has just been a challenge," Chris Hammond, executive vice president of sales at Great Dane, told FreightWaves during a May 27 interview in his office in Savannah, Georgia. "We lost some to different industries. Labor participation is lower than it was, and that affects everybody."

<hr />

<blockquote>
"Getting people back has just been a challenge. We lost some to different industries. Labor participation is lower than it was, and that affects everybody."
Chris Hammond, executive vice president of sales at Great Dane</blockquote>

<hr />

There is no waning demand, according to Frank Maly, ACT director of commercial vehicle transportation analysis and research.

ACT's U.S. Tractor Dashboard for June, which measures the potential strength of the tractor market, rose to its maximum value of 15. That means strong conditions exist across the entire commercial vehicle market, Maly said.

<h2 id="h-waiting-game">Waiting Game</h2>

Right now, it is a waiting game on several fronts. What will happen to spiking commodity prices for key items like steel and aluminum? Trailer manufacturers are loath to begin writing orders for 2022 until they have better visibility on commodity prices and can accurately quote the cost of new equipment.

<img src="https://lh5.googleusercontent.com/83qa9lA8OHMAngseljoI3SLadQS6HFjo2MJVgO-b9h-ZB4_oqJHP4ThG89aoYyFjDQOfT_l66AMvbdKacVYSTP3X1EKXMJ3tFtfss5sslF6vNdweYxB4cqQ2agVXcLCSzdXJdAQA" alt="83qa9lA8OHMAngseljoI3SLadQS6HFjo2MJVgO-b" />

"Orders will again begin to flow once OEMs are satisfied that materials/component pricing and supply, along with adequate staff, are in place to allow them to make further 2022 production commitments and satisfy robust fleet demand," Maly said.

One ongoing challenge for manufacturers is to ramp production in response to robust fleet demand, which is evident in nine- to 11-month backlog-to-build times since December. 

Even with a slight improvement in backlog-to-build rates to 9.1 months in May, the industry is essentially sold out through next March. Dry vans and refrigerated trailers extend into April and May, respectively, Maly said.

<h2 id="h-no-record-pace">No Record Pace</h2>

"We're not building at a record pace this year because of getting people into the plants, challenges of getting all these things that are scarce right now," Hammond said. "So, it's pushing that demand out."

The weak order numbers for May suggest some fleets are adjusting their requirements due to extended lead times. 

"Freight growth remains robust. Fleets continue to need more trailers than can be produced in the short term," Ake said."The environment is expected to improve in the second half of the year but will still impact the industry well into 2022."

<h2 id="h-related-articles">Related articles:</h2>

<a href="https://www.freightwaves.com/news/april-trailer-orders-slide-but-blow-away-near-zero-builds-a-year-ago">April trailer orders slide but blow away near-zero builds a year ago</a>

<a href="https://www.freightwaves.com/news/march-trailer-orders-stabilize-but-supply-chain-issues-stunt-production">March trailer orders stabilize but supply chain issues stunt production</a>

<a href="https://www.freightwaves.com/news/chip-shortage-pushing-capacity-starved-fleets-to-used-equipment">Chip shortage pushing capacity-starved fleets to used equipment</a>

<a href="https://www.freightwaves.com/news/author/alanadler">Click for more FreightWaves articles by Alan Adler.</a>

Image by <a href="https://pixabay.com/users/tama66-1032521/?utm_source=link-attribution&amp;utm_medium=referral&amp;utm_campaign=image&amp;utm_content=2920533">Peter H</a> from <a href="https://pixabay.com/?utm_source=link-attribution&amp;utm_medium=referral&amp;utm_campaign=image&amp;utm_content=2920533">Pixabay</a>

Commodities

Trailer Builders Get Respite In May As Orders Edge Back Toward Normalcy

<a href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.beigene.com%2F&amp;esheet=52447191&amp;newsitemid=20210618005318&amp;lan=en-US&amp;anchor=BeiGene%2C+Ltd.&amp;index=1&amp;md5=e64b878ed2ee3ec1913354185c240c1d">BeiGene, Ltd.</a>&nbsp;(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BGNE#NASDAQ">BGNE</a>, HKEX: 06160)))), a global biotechnology company focused on developing and commercializing innovative medicines worldwide, today announced that BRUKINSA&reg;&nbsp;(zanubrutinib) has received conditional approval from the China National Medical Products Administration (NMPA) for the treatment of adult patients with Waldenstr&ouml;m&#39;s macroglobulinemia (WM) who have received at least one prior therapy. The supplemental new drug application was previously granted priority review by the Center for Drug Evaluation (CDE) of the NMPA in October 2020.
&quot;With NMPA approval for BRUKINSA, our next generation BTK inhibitor, we are proud to be able to offer patients, their families, and physicians a new option for treating WM, an incurable disease that can cause significant morbidities,&quot; said Xiaobin Wu, Ph.D., General Manager of China and President of BeiGene. &quot;This marks BRUKINSA&#39;s third approval for the treatment of B-cell malignancies in China, and we believe it may serve an important role in addressing unmet needs for patients with blood cancers around the world.&quot;

BGNE

BeiGene Announces China NMPA Approval of BRUKINSA for the Treatment of Patients with Relapsed or Refractory Waldenström's Macroglobulinemia

CytRx Corporation (OTCQB:<a class="ticker" href="https://www.benzinga.com/stock/CYTR#OTCQB">CYTR</a>) (&quot;CytRx&quot;), a specialized biopharmaceutical company focused on research and development for the oncology and neurodegenerative disease categories, today noted that Orphazyme A/S (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ORPH#NASDAQ">ORPH</a>) (&quot;Orphazyme&quot;) announced it has received a Complete Response Letter (&ldquo;CRL&rdquo;) from the U.S. Food and Drug Administration (&ldquo;FDA&rdquo;) following its review of the new drug application for arimoclomol, a heat shock protein amplifier intended for the treatment of Niemann-Pick disease type C (&ldquo;NPC&rdquo;).
Orphazyme&rsquo;s announcement disclosed that the FDA issued the CRL based on needing additional qualitative and quantitative evidence to further substantiate the validity and interpretation of the 5-domain NPC Clinical Severity Scale (&ldquo;NPCCSS&rdquo;) and, in particular, the swallow domain. Further, the FDA noted in the CRL that additional data are needed to bolster confirmatory evidence beyond the single phase 2/3 clinical trial to support the benefit-risk assessment of the NDA.
A primary endpoint of the phase 2/3 clinical trial was progression in disease severity as measured by the 5-domain NPCCSS. This is a disease-specific measure of disease progression consisting of the five clinically most relevant domains to patients with NPC, caregivers and physicians.
Orphazyme CEO Christophe Bourdon stated: &ldquo;We are disheartened by the outcome of the FDA&rsquo;s review, given the urgent need for a new therapeutic option for NPC, but we remain committed to working with the regulators, with the goal of delivering arimoclomol to families managing this challenging disease. We will focus our efforts on pursuing the European regulatory approval, with CHMP opinion expected in Q4 2021 and potential Marketing Authorization in Q1 2022. We are assessing the potential path forward in the U.S. in partnership with the FDA. In the short-term, we will need to reduce our costs substantially and freeze all company efforts not related to clinical and regulatory activities to support approval for NPC.&rdquo;
Orphazyme disclosed that as stated in its Annual Report 2020, initial outlook for the year was subject to various risks and uncertainties, including but not limited to the timing of regulatory decisions, the success of Orphazyme&rsquo;s commercial efforts and development activities. The outcome of the FDA decision has significant influence on Orphazyme&rsquo;s outlook for full-year 2021. Orphazyme&rsquo;s cash position at year-end 2021 is now expected to be approximately $8 million (previously $56 million).
Orphazyme noted it will provide an update and further information in the coming weeks.

CYTR

ORPH

CytRx Comments On Orphazyme Complete Response Letter From FDA

The 2021 Formula 1 season enters its seventh race of the season at Circuit Paul Ricard in France.
Last race at Baku, chaos ensued for the two championship leaders Max Verstappen and Lewis Hamilton as both suffered problems at the end of the race. Verstappen blew a tire and lost a very comfortable lead while Hamilton overshot the first corner on the restart. Sergio Perez won his first race with Red Bull with Sebastian Vettel and Pierre Gasly joining him on the podium.
Entering France, Verstappen holds a narrow four-point gap over Hamilton in the driver standings while Red Bull extended its lead over Mercedes in the constructor championship to 26. However, Hamilton is still considered the championship favorite at -150 according to BetMGM. Verstappen is at +110 while Mercedes leads the constructor betting odds at -135. Red Bull is +100 despite leading the standings.
French Grand Prix:&nbsp;Hamilton is the favorite to win in France. He is 2-2 in the win category at the track and Mercedes dominated both races in 2018 and 2019. Hamilton won both from the pole while Valterri Bottas qualified second. Hamilton is the favorite at +110 to win while Verstappen is at +150, according to Bet365.
The two favorites are no surprise as they have dominated the 2021 season.
Perez is +1000 to win while Bottas is +800. Bottas has disappointed this season and is thought to be fighting for his job at Mercedes. He needs a good qualifying effort and race to boost Mercedes in the constructor standings. If either of the top two experience trouble, Bottas and Perez should be right in line to pick up the win.
Other bets to watch:&nbsp;Head-to-head teammate bets are always ones to watch in F1. For the most part, one teammate is always a justified heavy favorite, but that can change with a mistake during the race. One pairing to keep an eye on is the Apline duo of Estaban Ocon and Fernando Alonso. Ocon has beaten out Alonso in five of the six races this season and is +140 to do it again.
As for other bets, BetMGM and other sportsbooks offer bets on qualifying, fastest lap, the number of drivers to lead a lap, margin of victory, and much more.
The 2021 French Grand Prix starts at 9&nbsp;a.m. EST on Sunday, June 20 on ESPN.

Formula 1 French Grand Prix Betting Preview: Can Max Verstappen, Lewis Hamilton Recover From Disastrous Race In Baku?

The Federal Reserve shifted market expectations in a significant way on Wednesday with its updated dot plot projections and commentary related to inflation.
The SPDR S&amp;P 500 ETF Trust (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/spy#NYSE">SPY</a>) is down 2% since Tuesday&rsquo;s close, and the yield curve in U.S. Treasuries has flattened significantly.
On Wednesday, the Fed raised its 2021 OCE inflation forecast by 1% from 2.4% to 3.4%, well above its long-term target of 2%. In addition, the latest dot plot suggests two rate hikes by the end of 2023. On Friday, St. Louis Fed President James Bullard told CNBC that the Fed has observed &ldquo;more inflation than we were expecting&rdquo; and could potentially raise interest rates by the end of 2022.
Market Fallout:&nbsp;RSM Chief Economist Joe Brusuelas said Fed credibility is at the heart of the market action in recent days.
&ldquo;The shape of the entire yield curve is resetting with a flatter slope as the spread between the 30-year less 5-year yield standing at 111 basis points down from 156 basis points as recently as May 13, 2021,&rdquo; Brusuelas said Friday.
&ldquo;This strongly implies that investors are pulling back on expectations of inflation remaining sticky and are beginning to price in a more benign inflation outlook in line with the Fed&rsquo;s forecast of a transitory or temporary increase in inflation this year and next that then falls back towards the intertemporal target of 2%.&rdquo;
While some investors are very concerned about elevated inflation levels, Brusuelas said the Fed&rsquo;s five-year, five-year forward inflation projection remains at just 2.17%.
&ldquo;From our point of view this is forward looking investors signaling to both buyers and sellers in financial markets, as well as the broader policymaking community, that the risks to the economic outlook linked to inflation are overblown,&rdquo; Brusuelas said.
As the market digests the recent Fed news, Brusuelas said the next major Fed-elated catalyst could come in late August when the Fed will likely talk more explicitly about tapering its asset purchases at the annual Jackson Hole Economic Symposium.
Benzinga&rsquo;s Take: A 1% jump in the Fed&rsquo;s inflation expectations may have spooked investors, but the Fed has repeatedly said the current inflation levels are &ldquo;transitory&rdquo; as the economy reopens fully following pandemic shutdowns. However, the bond market is now pricing in a <a href="https://www.cmegroup.com/trading/interest-rates/countdown-to-fomc.html">42.3% chance</a> of at least one rate hike by July 2022, suggesting rising prices may force the Fed to take action much sooner than its 2024 expectations back in March.

Analyst Color

Economics

Federal Reserve

Analyst Ratings

Economist Reacts To Flattening Yield Curve

The NBA head coaching carousel is underway with seven vacancies.
With news this week that Stan Van Gundy will not return to the New Orleans Pelicans, Rick Carlisle to the Dallas Mavericks and several other team staff changes, there are plenty of top jobs open around the league. The seven jobs available are with New Orleans, Boston, Dallas, Washington, Portland, Orlando&nbsp;and Indiana.
Taking into account current rosters, salary cap flexibility, market&nbsp;and future expectations, here are the best (and worst) NBA head coaching jobs available.
Best job: Dallas Mavericks
After a report from The Athletic exposed dysfunction in the organization, both the general manager and head coach have left the organization. Now that issue is&nbsp;resolved, the Mavericks job will instantly become the most attractive for one reason: Luca Doncic. The 22-year-old superstar is one of the best players in the league and has made the All-NBA 1st team in each of the past two seasons.
Doncic is built to have postseason success and, while there are some restrictions on the roster around him, could still land a star running mate for next season. Owner Mark Cuban is adamant about his desire to win and with Doncic on the roster, that is a real possibility for any new head coach.
2. Boston Celtics
After news broke of the Celtics trading <a href="https://www.benzinga.com/news/21/06/21625715/kemba-walker-traded-to-oklahoma-city-al-horford-headed-back-to-boston-what-does-this-mean-for-both-t">Kemba Walker</a> to the Oklahoma City Thunder, the dynamic of this job changed. Brad Stevens, now atop the front office for Boston, moved Walker and clearly showed the future is in the hands of Jaylen Brown and Jayson Tatum.
The new head coach will have a talented roster to work with and the support of Stevens and ownership.
While Boston lacks a Doncic-like talent, the team is strong and Stevens will continue to be aggressive in building a winner.
3. New Orleans Pelicans
Any head coaching position involving a superstar young talent is attractive. Despite rumors of Zion Williamson&rsquo;s family being upset with the organization and wanting a trade, he is still a member of the team and an asset to the new head coach.
The pressure will immediately be on making the playoffs, but the team is talented enough to do so. Williamson and Brandon Ingram, alongside Lonzo Ball and Josh Hart (both of whom are restricted free agents) are good enough to make the playoffs.
The question is will the team be able to build around Williamson to keep him in New Orleans, or will the new head coach only have him around a short while.
4. Indiana Pacers
Despite lacking a superstar player, the Pacers job is a solid one. The team exited the playoffs in the first round this season but has the talent to make it again next year.
The roster is solid across the board and the label of &ldquo;solid-but-unspectacular&rdquo; makes this job one with reasonable expectations. Indiana is a playoff team without a superstar, but is an appealing opening.
5. Portland Trail Blazers
Damian Lillard&rsquo;s future in Portland is uncertain, giving this job a question mark hanging over it. If he stays, the pressure will be on the new head coach to win immediately and make a deep playoff run. If not, they could be one-and-done.
Instability makes for bad openings, but if the pieces stay the same, the Trail Blazers will be one of the better teams searching for a head coach. Lillard is a top-10 player, but consistent losses early in the postseason make this opening a shaky one.
6. Washington Wizards
The presence of Bradley Beal and Russell Westbrook gives Washington a good chance at reaching the playoffs next season. The team lacks cap flexibility to improve the team much and the duo of Westbrook and Beal is not good enough to truly contend in the Eastern Conference.
While the Wizards will be a low seed in the playoffs, the upside of this opening is not very high.
Worst job: Orlando Magic
The Magic are entering a full-fledged rebuild. Of all the teams with a coaching vacancy, the Magic is the only one without a shot at making the playoffs.
This job will likely go to a younger coach looking to prove themselves to a young and rebuilding group of players. While that could result in a new coach breaking out as a rising star, the Magic are not going to be good for at least several years.
(Photo:<a href="https://unsplash.com/@tjdragotta"> TJ Dragotta </a>via <a href="https://unsplash.com/">Unsplash)</a>
&nbsp;
&nbsp;

7 NBA Head Coaching Vacancies: Ranking The Most — And Least — Attractive Jobs Available

A Wedbush Securities analyst is bullish on shares of DocuSign, Inc (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/docu#NASDAQ">DOCU</a>). Here&#39;s what investors need to know.&nbsp;
The DocuSign Analyst:&nbsp;Daniel Ives maintained an Outperform rating on shares of DocuSign and raised the&nbsp;price target from $260 to $290.
The DocuSign Takeaways: DocuSign addresses a key issue that many organizations face in trying to accelerate moves to digital platforms, Ives said.
IT decision makers at many enterprises are prioritizing the use of DocuSign&rsquo;s solution set and e-signature platform as a way to manage contracts and paperwork with remote workers, the analyst said.&nbsp;
Going forward, as work from home continues to become a more common choice for employees, DocuSign&rsquo;s ability to &ldquo;further penetrate existing as well as new customers&rdquo; has largely increased, he said.&nbsp;
This penetration stems from DocuSign&rsquo;s software based cloud platform&rsquo;s ability to streamline traditional contracting processes for companies looking to cut down on the time involved with this contracting and typical highly redundant costs, the analyst said.
Additionally, DocuSign&rsquo;s Agreement Cloud and its contract lifecycle management offering SpringCM&nbsp;continue to expand the company&rsquo;s software offerings throughout entire deal processes &mdash; a major differentiator in this environment, he said.&nbsp;
In a broad view of the company, Ives said its &ldquo;plug and play features, ease of use, brand awareness, high technical expertise, and network effect (APIs)&rdquo; are key drivers for DocuSign&rsquo;s success in building its strong market presence.
DOCU Price Action: DocuSign shares gained 5.3% Friday, closing at $274.43.&nbsp;

Price Target

Reiteration

DOCU

Why This DocuSign Analyst Is Bullish

U.S. indices were trading lower Friday after St. Louis Fed President Bullard suggested rate hikes could come in late 2022 and said the Fed has opened taper discussions this week.
<ul>
<li>The SPDR Dow Jones Industrial Average ETF Trust (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/dia#NASDAQ">DIA</a>) fell by 1.35% to $414.92</li>
<li>The Invesco QQQ Trust Series 1 (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/qqq#NASDAQ">QQQ</a>) finished lower by 0.78% to $342.63</li>
<li>The SPDR S&amp;P 500 ETF Trust (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/spy#NASDAQ">SPY</a>) lost 1.5% to $332.96</li>
<li>Here are the day&#39;s winners and losers from the DIA, according to data from <a href="https://pro.benzinga.com/">Benzinga Pro</a>.</li>
</ul>
The Dow Jones was without gainers Friday.
Intel Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/intc#NASDAQ">INTC</a>), Walgreens Boots Alliance Inc (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/wba#NASDAQ">WBA</a>) and Goldman Sachs Group Inc (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/gs#NYSE">GS</a>) were among the top losers in the Dow Jones.
<h3>Elsewhere On The Street</h3>
The fast-food industry spends $5 billion on advertising and is disproportionately targeting children in general and Black and Latino youth in particular&hellip; <a href="https://www.benzinga.com/news/21/06/21626432/fast-food-industry-takes-aim-at-children-with-5b-advertising-spending-report">Read More</a>
Shares of Adobe Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/adbe#NASDAQ">ADBE</a>)&nbsp; have been ripping higher. Since the beginning of the month, they have gained more than 10%... <a href="https://www.benzinga.com/trading-ideas/short-ideas/21/06/21625500/is-it-time-to-sell-adobe-stock">Read More</a> 
General Electric Co. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/ge#NYSE">GE</a>) shares were moving down Friday following the company&rsquo;s announcement of a 1-for-8 reverse split with an effective date of Aug. 2, 2021 that was approved by shareholders last month&hellip; <a href="https://www.benzinga.com/trading-ideas/long-ideas/21/06/21626668/heres-where-general-electric-stock-could-find-support">Read More</a>

ADBE

SPDR Dow Jones Industrial Average ETF Trust

INTC

Intel And Walgreens Lead The Dow Jones Lower Friday

<h3>Fyllo Taps Wes Chaar For&nbsp;Its Leadership Team</h3>
Cannabis technology platform Fyllo has <a href="https://www.benzinga.com/markets/cannabis/21/06/21564187/fyllo-continues-hiring-streak-with-former-catalina-exec-wes-chaar-as-chief-data-analytics-office">appointed</a> Wes Chaar to serve as chief data and analytics officer.
Chaar brings extensive experience in data strategy, data fusion, mathematical modeling, machine learning&nbsp;and artificial intelligence.
He agreed to lead the Data Solutions team of the Chicago-based company in its mission to help cannabis and CBD endemic and non-endemic brands to reach cannabis consumers.
Prior to joining Fyllo, Chaar served as chief data and analytics officer for three years at Catalina USA, one of the largest names in retail shopping data.
&quot;I look forward to bringing my experience across industries to cannabis and enabling marketers to find and reach this coveted audience,&quot; Chaar said earlier this week.
<h3>Shelter Cannabis Names New CEO</h3>
Shelter Cannabis announced Monday that it had&nbsp;named Michael Nederhoff as its new CEO, replacing Mark Hauk, founder and former CEO, who&nbsp;stepped down but will remain&nbsp;a strategic advisor to the company.
Nederhoff brings vast knowledge in consumer-packaged goods, highly regulated industries, retail, and manufacturing. In addition, he has more than 25 years of management experience.
Prior to this, Nederhoff served as president of JUUL Labs Canada.
&quot;Michael brings strong commercial expertise, as well as a passion for Shelter&#39;s future growth and success.&quot; Hauk disclosed. &quot;The Shelter Executive and I firmly believe that under Michael&#39;s leadership, Shelter&#39;s strategic direction going forward will be characterized by leading market performance, sustainable growth, and profitability.&quot;
<h3>Khiron Promotes Franziska Katterbach To President, Tejinder Virk Resigns</h3>
Vertically integrated medical cannabis company Khiron Life Sciences Corp. (TSXV: KHRN) (OTCQX: <a class="ticker" href="https://www.benzinga.com/stock/khrnf#OTCQX">KHRNF</a>) has promoted Franziska Katterbach to serve as president of Khiron Europe&nbsp;to replace Tejinder Virk, who opted to resign.
Katterbach joined the Toronto-based company in October 2019 to serve as managing director and chief legal counsel of Khiron Europe.
Alvaro Torres, Khiron&rsquo;s CEO and director, praised Katterbach&rsquo;s skills, calling her the &ldquo;driving force behind our European operations.&rdquo;
&ldquo;Her regulatory expertise, strong leadership skills, and exceptional day-to-day management of operations have allowed us to develop a differentiated, asset-light platform,&rdquo; Torres said Monday.
<h3>Amfil Technologies Names New COO</h3>
Amfil Technologies, Inc. (OTC: <a class="ticker" href="https://www.benzinga.com/stock/funn#OTC">FUNN</a>), owner of Snakes &amp; Lattes board game cafes that earlier announced it was&nbsp;entering the cannabis dispensary business in Canada, has hired Aaron McKay to serve as chief operating officer.
McKay, who was tapped to serve as vice president of food and beverages at Snakes &amp; Lattes last year,&nbsp;brings vast corporate and management experience.
&quot;Aaron brings decades of restaurant and management experience to this role,&quot; Ben Castanie, Snakes &amp; Lattes founder, said Tuesday. &quot;Aaron&#39;s discipline and sense of organization coupled with a deep understanding of our business make him the ideal candidate to lead operations of the organization.&quot;
The Toronto-based company is also launching its first dispensary in Canada this summer through its wholly-owned subsidiary FUNN Dispensaries, Inc.
<h3>Creo Names Dr. Joel Cherry Its New Chief Technology Officer</h3>
Cannabinoid ingredient company Creo has welcomed Dr. Joel Cherry to its leadership team.
The San Diego, California-based company said Tuesday that Cherry agreed to serve as its chief technology officer.
Cherry has more than 25 years of experience developing and producing high-value organic molecules using advanced biology.
Prior to this, he served as president of research and development at Amyris.
Roy Lipski, CEO and co-founder of Creo, said&nbsp;Cherry&nbsp; brings &ldquo;world-class technical and development expertise, along with a track record of working closely with industry and consumer brands.&rdquo;
<h3>Willow Industries Hires Tess Eidem, Ph.D. As Director Of Science</h3>
Willow Industries Inc. confirmed Tuesday that it has hired Tess Eidem, Ph.D., as director of science.
Eidem agreed to expand and standardize Willow&#39;s onboarding processes in order to secure that &quot;healthy practices are put in place&quot; in the company&#39;s work with partners&#39; operations and cultivation teams.
Eidem previously served at Columbia Care, Inc. (NEO: CCHW) (CSE: CCHW) (OTCQX: <a class="ticker" href="https://www.benzinga.com/stock/cchwf#OTCQX">CCHWF</a>) (FSE: 3LP) as lab&nbsp;manager.
&quot;Willow was founded to promote clean cannabis and healthy plants, so expanding our scientific knowledge base is essential to that core mission of the company,&quot; Jill Ellsworth, CEO and founder of Willow, disclosed. &quot;Tess&#39;s expertise brings another layer to pinpointing where contamination is coming from, and mitigating it as much as possible before implementing a kill step.&quot;
<h3>Charlotte&#39;s Web Holdings Names Wessel Booysen CFO</h3>
Hemp CBD extract producer Charlotte&#39;s Web Holdings, Inc. (TSX: CWEB) (OTCQX: <a class="ticker" href="https://www.benzinga.com/stock/cwbhf#OTCQX">CWBHF</a>) confirmed Tuesday that Wessel Booysen has agreed to oversee its finance department, succeeding Russ Hammer, who will retire in August.
Booysen spent over a decade at Molson Coors Beverage Company (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/tap#NYSE">TAP</a>), sharpening his skills in finance, international expansion, and strategic merger and acquisitions.
Prior to this, he worked at Deloitte in Assurance and Advisory, overseeing mergers and acquisitions, business transformation, public offerings&nbsp;and SEC reporting for more than ten years.
&quot;Wes&#39;s background in the internationally regulated alcoholic beverage business is highly applicable to our sector. His technical acumen and financial planning &amp; reporting experience will also be instrumental in our forward expansion plans,&quot; said Deanie Elsner, CEO of Charlotte&#39;s Web.
Photo by <a href="https://unsplash.com/@daconja?utm_source=unsplash&amp;utm_medium=referral&amp;utm_content=creditCopyText">David Gabrić</a> on <a href="https://unsplash.com/s/photos/cannabis?utm_source=unsplash&amp;utm_medium=referral&amp;utm_content=creditCopyText">Unsplash</a>

Entrepreneurship

Movers & Shakers

CWBHF

FUNN

KHIRON LIFE SCIENCES CORP by Khiron Life Sciences Corp.

KHRNF

Cannabis Movers & Shakers: Fyllo, Shelter Cannabis, Khiron, Amfil Technologies, Creo, Willow Industries, Charlotte's Web

The market and the economy continue to open, which is probably a result of bottled-up demand for many products and services affected by the pandemic. Maybe the inflation or rising bond yields will trigger the selloff on the market at some moment, but the current Fed&#39;s transitory inflation message has been accepted by many investors. Also, the best way to deal with inflation is to stay with your investments and keep your faith in the market. So, despite the jump of May&#39;s consumer-price index, that did not affect the investors who adopted a different mindset, so all three major averages finished in a positive zone.
The Dow Jones Industrial Average managed to recover from one of the steeper declines, thanks to gains from companies like IBM (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/ibm#NYSE">IBM</a>), Microsoft (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/msft#NASDAQ">MSFT</a>), and Salesforce (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/crm#NYSE">CRM</a>). The Nasdaq Composite Index has also risen 49.09 points to 14,069.42. The tech-heavy index continued with the positive run, led by DocuSign (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/docu#NASDAQ">DOCU</a>), Zoom Video (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/zm#NASDAQ">ZM</a>), and CrowdStrike (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/crwd#NASDAQ">CRWD</a>).
Tuesday Brought Us An Earnings Report From Oracle
Although it was a slim week for the earnings reports, Oracle (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/orcl#NYSE">ORCL</a>) announced its last quarter results, as well as plans and guidance. The results are better than expected, as the achieved revenues were $11.23 billion (compared to the expected $11.04 billion) and the achieved adjusted earnings of&nbsp;$1.54 per share (compared to the expected $1.31). On the other hand, the company revealed its quarterly revenue guidance, which is lower than expected due to the plans to increase investments to support its cloud strategy and keep migrating existing on-premises customers to the cloud. This all led to a sharp fall of 5%, as many investors are skeptical if Oracle can successfully compete with major &quot;cloud&quot; players like Amazon (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/amzn#NASDAQ">AMZN</a>), Salesforce, or Workday (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/wday#NASDAQ">WDAY</a>).
Adobe Reported Impressive Results On Thursday
The Wall Street analysts recognized the work-from-home trend and this second digitization era as the main reasons for Adobe&#39;s (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/adbe#NASDAQ">ADBE</a>) sustained growth and therefore a monster quarter. And they were right. The company reported revenues of $3.84 billion, which is an increase of 23% compared year to year. That is also above the Wall Street estimate of $3.73 billion. The digital media business revenues, consisting of Creative Cloud and Document Cloud, grew by 25% compared to the previous year. The adjusted earnings per share were $3.03, which is higher than the estimated $2.81. For the following quarter, the company expects revenues of $3.88 billion and adjusted earnings per share of $3.00.
Conclusion
All these factors taken together, proven by positive index movements and earnings results better than anticipated, support the fact that the economic recovery is firmly underway, and those are very encouraging news.
This article is not a press release and is contributed by a verified independent journalist for IAMNewswire. It should not be construed as investment advice at any time please read the full <a href="https://iamnewswire.com/disclaimer-disclosure/">disclosure</a>. IAM Newswire does not hold any position in the mentioned companies. Press Releases &ndash; If you are looking for full Press release distribution contact: <a href="mailto:press@iamnewswire.com">press@iamnewswire.com</a> Contributors &ndash; IAM Newswire accepts pitches. If you&#39;re interested in becoming an IAM journalist contact: <a href="mailto:contributors@iamnewswire.com">contributors@iamnewswire.com</a>
The post <a href="https://iamnewswire.com/this-weeks-recap/" rel="nofollow">This Week&#39;s Recap</a> appeared first on <a href="https://iamnewswire.com" rel="nofollow">IAM Newswire</a>.
Image by <a href="https://pixabay.com/users/clearcutltd-6110302/?utm_source=link-attribution&amp;utm_medium=referral&amp;utm_campaign=image&amp;utm_content=4608125">Tawanda Razika</a> from <a href="https://pixabay.com/?utm_source=link-attribution&amp;utm_medium=referral&amp;utm_campaign=image&amp;utm_content=4608125">Pixabay</a>

AMZN

CRWD

MSFT

ORCL

WDAY

This Week's Market Recap: June 18, 2021

Baudax Bio, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BXRX#NASDAQ">BXRX</a>), a pharmaceutical company focused on developing and commercializing innovative products for acute care settings, today announced that it has scheduled a Special Meeting of shareholders to approve its proposed increase of the number of authorized shares of common stock from 100 million shares to 190 million shares for Tuesday, July 13, 2021 at 9:00 a.m. Eastern Time. The proposal to increase the Company&#39;s authorized shares of capital stock is set forth in its Definitive Proxy Statement filed with the Securities and Exchange Commission on June 14, 2021. 
&nbsp;
Leading independent proxy advisory firms Glass Lewis &amp; Co. and Institutional Shareholder Services, Inc. have both recommended that Baudax Bio shareholders vote &quot;for&quot; the proposed additional authorized shares. The Special Meeting will be held virtually at&nbsp;<a href="https://www.globenewswire.com/Tracker?data=GbNoBElhKpBWn60CX4rJQf3E0F20B9HC8mPNJq6mOWTYGetvwEJiMK-XDHYkz0n6pITcsFtq_AHr892Z_T9b_maOptQAKiRKRHUQjJkn3AAmZN55d73LYgplxthUca6VZgKwTVOphPkpNg9dDqhrgwjsu9BCA0Xe9yLE7F_7iJI=" target="_blank">www.virtualshareholdermeeting.com/BXRX2021</a>.

BXRX

Baudax Bio Announces Special Meeting of Shareholders to Vote on Proposed Increase in Number of Authorized Shares of Common Stock

<h3>Gainers</h3>

<ul>
	<li>Hollister Biosciences&nbsp;(OTC:<a class="ticker" href="/stock/HSTRF#OTC">HSTRF</a>) shares closed up 37.97% at $0.10</li>
	<li>Item 9 Labs&nbsp;(OTC:<a class="ticker" href="/stock/INLB#OTC">INLB</a>) shares closed up 23.38% at $0.95</li>
	<li>AusCann Group Holdings&nbsp;(OTC:<a class="ticker" href="/stock/ACNNF#OTC">ACNNF</a>) shares closed up 20.56% at $0.11</li>
	<li>Cann Group&nbsp;(OTC:<a class="ticker" href="/stock/CNGGF#OTC">CNGGF</a>) shares closed up 13.93% at $0.37</li>
	<li>GrowGeneration&nbsp;(NASDAQ:<a class="ticker" href="/stock/GRWG#NASDAQ">GRWG</a>) shares closed up 13.3% at $8.52</li>
	<li>The Scotts Miracle Gro&nbsp;(NYSE:<a class="ticker" href="/stock/SMG#NYSE">SMG</a>) shares closed up 11.67% at $162.57</li>
	<li>CordovaCann&nbsp;(OTC:<a class="ticker" href="/stock/LVRLF#OTC">LVRLF</a>) shares closed up 9.76% at $0.32</li>
	<li>Greenlane Holdings&nbsp;(NASDAQ:<a class="ticker" href="/stock/GNLN#NASDAQ">GNLN</a>) shares closed up 9.35% at $3.86</li>
	<li>48North Cannabis&nbsp;(OTC:<a class="ticker" href="/stock/NCNNF#OTC">NCNNF</a>) shares closed up 8.83% at $0.15</li>
	<li>Harvest Health&nbsp;(OTC:<a class="ticker" href="/stock/HRVSF#OTC">HRVSF</a>) shares closed up 6.83% at $1.04</li>
	<li>Nine Energy Service&nbsp;(NYSE:<a class="ticker" href="/stock/NINE#NYSE">NINE</a>) shares closed up 4.69% at $2.01</li>
	<li>Marrone Bio Innovations&nbsp;(NASDAQ:<a class="ticker" href="/stock/MBII#NASDAQ">MBII</a>) shares closed up 4.42% at $1.18</li>
	<li>World Acceptance&nbsp;(NASDAQ:) shares closed up 4.06% at $71.07</li>
	<li>GreenTree Hospitality Gr&nbsp;(NYSE:<a class="ticker" href="/stock/GHG#NYSE">GHG</a>) shares closed up 3.83% at $12.61</li>
</ul>

<h3>Losers</h3>

<ul>
	<li>Benchmark Botanics&nbsp;(OTC:<a class="ticker" href="/stock/BHHKF#OTC">BHHKF</a>) shares closed down 27.88% at $0.15</li>
	<li>Aphria&nbsp;(NASDAQ:<a class="ticker" href="/stock/APHA#NASDAQ">APHA</a>) shares closed down&nbsp;19.17% at $4.85</li>
	<li>Bloom Energy&nbsp;(NYSE:<a class="ticker" href="/stock/BE#NYSE">BE</a>) shares closed down 14.26% at $12.85</li>
	<li>NexTech AR Solns&nbsp;(OTC:<a class="ticker" href="/stock/NEXCF#OTC">NEXCF</a>) shares closed down 10.53% at $4.35</li>
	<li>Aurora Cannabis&nbsp;(NYSE:<a class="ticker" href="/stock/ACB#NYSE">ACB</a>) shares closed down 8.54% at $10.66</li>
	<li>Cansortium&nbsp;(OTC:<a class="ticker" href="/stock/CNTMF#OTC">CNTMF</a>) shares closed down 8.33% at $0.33</li>
	<li>Tilray&nbsp;(NASDAQ:<a class="ticker" href="/stock/TLRY#NASDAQ">TLRY</a>) shares closed down 7.27% at $7.53</li>
	<li>Charlottes Web Holdings&nbsp;(OTC:<a class="ticker" href="/stock/CWBHF#OTC">CWBHF</a>) shares closed down 6.33% at $3.59</li>
	<li>Corbus Pharmaceuticals&nbsp;(NASDAQ:<a class="ticker" href="/stock/CRBP#NASDAQ">CRBP</a>) shares closed down 6.26% at $6.44</li>
	<li>Green Organic Dutchman&nbsp;(OTC:<a class="ticker" href="/stock/TGODF#OTC">TGODF</a>) shares closed down 6.02% at $0.30</li>
	<li>Canopy Growth&nbsp;(NYSE:<a class="ticker" href="/stock/CGC#NYSE">CGC</a>) shares closed down 4.93% at $18.52</li>
	<li>Cronos Group&nbsp;(NASDAQ:<a class="ticker" href="/stock/CRON#NASDAQ">CRON</a>) shares closed down 4.66% at $6.75</li>
	<li>Curaleaf Holdings&nbsp;(OTC:<a class="ticker" href="/stock/CURLF#OTC">CURLF</a>)&nbsp;shares closed down 4.65% at $8.20</li>
	<li>OrganiGram Holdings&nbsp;(NASDAQ:<a class="ticker" href="/stock/OGI#NASDAQ">OGI</a>) shares closed down 3.68% at $1.31</li>
</ul>

Lead image by Ilona Szentivanyi. Copyright: Benzinga.

Cannabis Stock Gainers And Losers From July 29, 2020

<h3>Gainers:</h3>

<ul>
	<li>iAnthus Capital Hldgs&nbsp;(OTC:<a class="ticker" href="/stock/ITHUF#OTC">ITHUF</a>) shares closed up 52.46% at $0.09</li>
	<li>Nova Mentis Life Science&nbsp;(OTC:<a class="ticker" href="/stock/LIBFF#OTC">LIBFF</a>) shares closed up 28.18% at $0.16</li>
	<li>GrowGeneration&nbsp;(NASDAQ:<a class="ticker" href="/stock/GRWG#NASDAQ">GRWG</a>) shares closed up 22.05% at $16.16</li>
	<li>Helix TCS&nbsp;(OTCQB:<a class="ticker" href="/stock/HLIX#OTCQB">HLIX</a>) shares closed up 18.59% at $0.19</li>
	<li>48North Cannabis&nbsp;(OTC:<a class="ticker" href="/stock/NCNNF#OTC">NCNNF</a>) shares closed up 18.33% at $0.14</li>
	<li>Genetic Technologies&nbsp;(NASDAQ:<a class="ticker" href="/stock/GENE#NASDAQ">GENE</a>) shares closed up 10% at $4.29</li>
	<li>C21 Investments&nbsp;(OTCQB:<a class="ticker" href="/stock/CXXIF#OTCQB">CXXIF</a>) shares closed up 9.22% at $0.45</li>
	<li>TerrAscend&nbsp;(OTCQX:<a class="ticker" href="/stock/TRSSF#OTCQX">TRSSF</a>) shares closed up 7.11% at $4.21</li>
	<li>NexTech AR Solns&nbsp;(OTCQB:<a class="ticker" href="/stock/NEXCF#OTCQB">NEXCF</a>) shares closed up 6.49% at $4.78</li>
	<li>Alcanna&nbsp;(OTC:<a class="ticker" href="/stock/LQSIF#OTC">LQSIF</a>) shares closed up 6.86% at $3.35</li>
	<li>Cresco Labs&nbsp;(OTCQX:<a class="ticker" href="/stock/CRLBF#OTCQX">CRLBF</a>) shares closed up 6.21% at $7.70</li>
	<li>Curaleaf Holdings&nbsp;(OTCQX:<a class="ticker" href="/stock/CURLF#OTCQX">CURLF</a>) shares closed up 4.58% at $9.43</li>
	<li>Arena Pharmaceuticals&nbsp;(NASDAQ:<a class="ticker" href="/stock/ARNA#NASDAQ">ARNA</a>) shares closed up 3.93% at $66.09</li>
	<li>GW Pharmaceuticals&nbsp;(NASDAQ:<a class="ticker" href="/stock/GWPH#NASDAQ">GWPH</a>) shares closed up 3.23% at $109.87</li>
	<li>Teradyne&nbsp;(NASDAQ:<a class="ticker" href="/stock/TER#NASDAQ">TER</a>) shares closed up 2.13% at $91.98</li>
</ul>

<h3>Losers:</h3>

<ul>
	<li>Benchmark Botanics&nbsp;(OTC:<a class="ticker" href="/stock/BHHKF#OTC">BHHKF</a>) shares closed down 16.48% at $0.13</li>
	<li>MGC Pharmaceuticals&nbsp;(OTC:<a class="ticker" href="/stock/MGCLF#OTC">MGCLF</a>) shares closed down 14% at $0.01</li>
	<li>Village Farms Intl&nbsp;(NASDAQ:<a class="ticker" href="/stock/VFF#NASDAQ">VFF</a>) shares closed down 10.14% at $5.14</li>
	<li>Halo Labs&nbsp;(OTCQX:<a class="ticker" href="/stock/AGEEF#OTCQX">AGEEF</a>) shares closed down 9.79% at $0.09</li>
	<li>Intec Pharma&nbsp;(NASDAQ:<a class="ticker" href="/stock/NTEC#NASDAQ">NTEC</a>) shares closed down 9.35% at $0.34</li>
	<li>Lexaria Bioscience&nbsp;(OTCQX:<a class="ticker" href="/stock/LXRP#OTCQX">LXRP</a>) shares closed down 7.73% at $0.34</li>
	<li>MariMed&nbsp;(OTCQX:<a class="ticker" href="/stock/MRMD#OTCQX">MRMD</a>) shares closed down 7.94% at $0.18</li>
	<li>Lexaria Bioscience&nbsp;(OTCQX:<a class="ticker" href="/stock/LXRP#OTCQX">LXRP</a>) shares closed down 7.73% at $0.34</li>
	<li>BioHarvest Sciences&nbsp;(OTC:<a class="ticker" href="/stock/CNVCF#OTC">CNVCF</a>) shares closed down 6.21% at $0.11</li>
	<li>InMed Pharmaceuticals&nbsp;(OTCQX:<a class="ticker" href="/stock/IMLFF#OTCQX">IMLFF</a>) shares closed down 5.92% at $5.00</li>
	<li>Aurora Cannabis&nbsp;(NYSE:<a class="ticker" href="/stock/ACB#NYSE">ACB</a>) shares closed down 5.43% at $10.11</li>
	<li>Harvest Health&nbsp;(OTCQX:<a class="ticker" href="/stock/HRVSF#OTCQX">HRVSF</a>) shares closed down 4.35% at $1.32</li>
</ul>

&nbsp;

Lead image by Ilona Szentivanyi. Copyright: Benzinga.

Cannabis Stock Gainers And Losers From August 17, 2020

<h3>GAINERS:</h3>

<ul>
	<li><a href="https://quotes.benzinga.com/quote/BHHKF" target="_blank">Benchmark Botanics</a>&nbsp;(OTC:<a class="ticker" href="/stock/BHHKF#OTC">BHHKF</a>) shares closed up 61.15% at $0.16</li>
	<li><a href="https://quotes.benzinga.com/quote/KSHB" target="_blank">KushCo Holdings</a>&nbsp;(OTCQX:<a class="ticker" href="/stock/KSHB#OTCQX">KSHB</a>) shares closed up 24.97% at $0.54</li>
	<li><a href="https://quotes.benzinga.com/quote/ZLDAF" target="_blank">Zelira Therapeutics</a>&nbsp;(OTCQB:<a class="ticker" href="/stock/ZLDAF#OTCQB">ZLDAF</a>) shares closed up 12.5% at $0.05</li>
	<li><a href="https://quotes.benzinga.com/quote/FFNTF" target="_blank">4Front Ventures</a>&nbsp;(OTCQX:<a class="ticker" href="/stock/FFNTF#OTCQX">FFNTF</a>) shares closed up 11.02% at $0.59</li>
	<li><a href="https://quotes.benzinga.com/quote/CNTMF" target="_blank">Cansortium</a>&nbsp;(OTCQB:<a class="ticker" href="/stock/CNTMF#OTCQB">CNTMF</a>) shares closed up 10.17% at $0.33</li>
	<li><a href="https://quotes.benzinga.com/quote/NINE" target="_blank">Nine Energy Service</a>&nbsp;(NYSE:<a class="ticker" href="/stock/NINE#NYSE">NINE</a>) shares closed up 8.94% at $1.34</li>
	<li><a href="https://quotes.benzinga.com/quote/INLB" target="_blank">Item 9 Labs</a>&nbsp;(OTCQX:<a class="ticker" href="/stock/INLB#OTCQX">INLB</a>) shares closed up 8.11% at $1.20</li>
	<li><a href="https://quotes.benzinga.com/quote/DRVD" target="_blank">Driven Deliveries</a>&nbsp;(OTCQB:<a class="ticker" href="/stock/DRVD#OTCQB">DRVD</a>) shares closed up 7.14% at $0.30</li>
	<li><a href="https://quotes.benzinga.com/quote/GNLN" target="_blank">Greenlane Holdings</a>&nbsp;(NASDAQ:<a class="ticker" href="/stock/GNLN#NASDAQ">GNLN</a>) shares closed up 4.89% at $2.09</li>
</ul>

<h3>LOSERS:</h3>

<ul>
	<li><a href="https://quotes.benzinga.com/quote/HERTF" target="_blank">Heritage Cannabis Holding</a>&nbsp;(OTCQX:<a class="ticker" href="/stock/HERTF#OTCQX">HERTF</a>) shares closed down&nbsp;15.26% at $0.06</li>
	<li><a href="https://quotes.benzinga.com/quote/ZBISF" target="_blank">Zenabis Global</a>&nbsp;(OTC:<a class="ticker" href="/stock/ZBISF#OTC">ZBISF</a>) shares closed down&nbsp;14.61% at $0.05</li>
	<li><a href="https://quotes.benzinga.com/quote/AGEEF" target="_blank">Halo Labs</a>&nbsp;(OTCQX:<a class="ticker" href="/stock/AGEEF#OTCQX">AGEEF</a>) shares closed down&nbsp;14.05% at $0.05</li>
	<li><a href="https://quotes.benzinga.com/quote/LXRP" target="_blank">Lexaria Bioscience</a>&nbsp;(OTCQX:<a class="ticker" href="/stock/LXRP#OTCQX">LXRP</a>) shares closed down&nbsp;13.22% at $0.28</li>
	<li><a href="https://quotes.benzinga.com/quote/MGCLF" target="_blank">MGC Pharmaceuticals</a>&nbsp;(OTC:<a class="ticker" href="/stock/MGCLF#OTC">MGCLF</a>) shares closed down 12.5% at $0.01</li>
	<li><a href="https://quotes.benzinga.com/quote/ICNAF" target="_blank">Icanic Brands</a>&nbsp;(OTCQB:<a class="ticker" href="/stock/ICNAF#OTCQB">ICNAF</a>) shares closed down 11.68% at $0.25</li>
	<li><a href="https://quotes.benzinga.com/quote/FLOOF" target="_blank">Flower One Hldgs</a>&nbsp;(OTCQX:<a class="ticker" href="/stock/FLOOF#OTCQX">FLOOF</a>) shares closed down 10.73% at $0.14</li>
	<li><a href="https://quotes.benzinga.com/quote/YCBD" target="_blank">cbdMd, Inc.</a>&nbsp;(AMEX:<a class="ticker" href="/stock/YCBD#AMEX">YCBD</a>) shares closed down 7.14% at $1.89</li>
	<li><a href="https://quotes.benzinga.com/quote/VIVO" target="_blank">Meridian Bioscience</a>&nbsp;(NASDAQ:<a class="ticker" href="/stock/VIVO#NASDAQ">VIVO</a>) shares closed down 6.75% at $15.55</li>
	<li><a href="https://quotes.benzinga.com/quote/APHA" target="_blank">Aphria</a>&nbsp;(NASDAQ:<a class="ticker" href="/stock/APHA#NASDAQ">APHA</a>) shares closed down 5.24% at $4.21</li>
	<li><a href="https://quotes.benzinga.com/quote/TGODF" target="_blank">Green Organic Dutchman</a>&nbsp;(OTCQX:<a class="ticker" href="/stock/TGODF#OTCQX">TGODF</a>) shares closed down 4.78% at $0.22</li>
	<li><a href="https://quotes.benzinga.com/quote/GTBIF" target="_blank">Green Thumb Industries</a>&nbsp;(OTCQX:<a class="ticker" href="/stock/GTBIF#OTCQX">GTBIF</a>) shares closed down 4.49% at $12.33</li>
	<li><a href="https://quotes.benzinga.com/quote/CURLF" target="_blank">Curaleaf Holdings</a>&nbsp;(OTCQX:<a class="ticker" href="/stock/CURLF#OTCQX">CURLF</a>) shares closed down 4.38% at $6.88</li>
</ul>

<a href="https://www.benzinga.com/cannabis/stocks/">Check out a full list of cannabis stock movers in real time following this link.</a>

Lead image by Ilona Szentivanyi. Copyright: Benzinga.

Cannabis Stock Gainers And Losers From September 24, 2020

<h3>GAINERS:</h3>

<ul>
	<li><a href="https://quotes.benzinga.com/quote/AGEEF" target="_blank">Halo Labs</a>&nbsp;(OTCQX:<a class="ticker" href="/stock/AGEEF#OTCQX">AGEEF</a>) shares closed up 32% at $0.07</li>
	<li><a href="https://quotes.benzinga.com/quote/MGCLF" target="_blank">MGC Pharmaceuticals</a>&nbsp;(OTC:<a class="ticker" href="/stock/MGCLF#OTC">MGCLF</a>) shares closed up 18.75% at $0.02</li>
	<li><a href="https://quotes.benzinga.com/quote/HERTF" target="_blank">Heritage Cannabis Holding</a>&nbsp;(OTCQX:<a class="ticker" href="/stock/HERTF#OTCQX">HERTF</a>) shares closed up 16.34% at $0.07</li>
	<li><a href="https://quotes.benzinga.com/quote/INLB" target="_blank">Item 9 Labs</a>&nbsp;(OTCQX:<a class="ticker" href="/stock/INLB#OTCQX">INLB</a>) shares closed up 15.74% at $1.25</li>
	<li><a href="https://quotes.benzinga.com/quote/CNVCF" target="_blank">BioHarvest Sciences</a>&nbsp;(OTC:<a class="ticker" href="/stock/CNVCF#OTC">CNVCF</a>) shares closed up 12.2% at $0.12</li>
	<li><a href="https://quotes.benzinga.com/quote/BE" target="_blank">Bloom Energy</a>&nbsp;(NYSE:<a class="ticker" href="/stock/BE#NYSE">BE</a>) shares closed up 11.27% at $16.88</li>
	<li><a href="https://quotes.benzinga.com/quote/NINE" target="_blank">Nine Energy Service</a>&nbsp;(NYSE:<a class="ticker" href="/stock/NINE#NYSE">NINE</a>) shares closed up 11.05% at $1.29</li>
	<li><a href="https://quotes.benzinga.com/quote/SOLCF" target="_blank">SOL Global Investments</a>&nbsp;(OTC:<a class="ticker" href="/stock/SOLCF#OTC">SOLCF</a>) shares closed up 9.2% at $0.95</li>
	<li><a href="https://quotes.benzinga.com/quote/CNTMF" target="_blank">Cansortium</a>&nbsp;(OTCQB:<a class="ticker" href="/stock/CNTMF#OTCQB">CNTMF</a>) shares closed up 6.06% at $0.35</li>
	<li><a href="https://quotes.benzinga.com/quote/FFNTF" target="_blank">4Front Ventures</a>&nbsp;(OTCQX:<a class="ticker" href="/stock/FFNTF#OTCQX">FFNTF</a>) shares closed up 5.58% at $0.62</li>
	<li><a href="https://quotes.benzinga.com/quote/WRLD" target="_blank">World Acceptance</a>&nbsp;(NASDAQ:<a class="ticker" href="/stock/WRLD#NASDAQ">WRLD</a>) shares closed up 5% at $99.97</li>
	<li><a href="https://quotes.benzinga.com/quote/CRBP" target="_blank">Corbus Pharmaceuticals</a>&nbsp;(NASDAQ:<a class="ticker" href="/stock/CRBP#NASDAQ">CRBP</a>) shares closed up 4.79% at $1.64</li>
</ul>

&nbsp;

<h3>LOSERS:</h3>

<ul>
	<li><a href="https://quotes.benzinga.com/quote/NCNNF" target="_blank">48North Cannabis</a>&nbsp;(OTC:<a class="ticker" href="/stock/NCNNF#OTC">NCNNF</a>) shares closed down&nbsp;26.67% at $0.11</li>
	<li><a href="https://quotes.benzinga.com/quote/ZLDAF" target="_blank">Zelira Therapeutics</a>&nbsp;(OTCQB:<a class="ticker" href="/stock/ZLDAF#OTCQB">ZLDAF</a>) shares closed down 21.15% at $0.04</li>
	<li><a href="https://quotes.benzinga.com/quote/TGODF" target="_blank">Green Organic Dutchman</a>&nbsp;(OTC:<a class="ticker" href="/stock/TGOFG#OTC">TGOFG</a>) shares closed down 14.94% at $0.19</li>
	<li><a href="https://quotes.benzinga.com/quote/ACB" target="_blank">Aurora Cannabis</a>&nbsp;(NYSE:<a class="ticker" href="/stock/ACB#NYSE">ACB</a>) shares closed down 5.55% at $4.78</li>
	<li><a href="https://quotes.benzinga.com/quote/VVCIF" target="_blank">VIVO Cannabis</a>&nbsp;(OTCQX:<a class="ticker" href="/stock/VVCIF#OTCQX">VVCIF</a>) shares closed down 5.38% at $0.13</li>
	<li><a href="https://quotes.benzinga.com/quote/EMHTF" target="_blank">Emerald Health</a>&nbsp;(OTCQX:<a class="ticker" href="/stock/EMHTF#OTCQX">EMHTF</a>) shares closed down 5.33% at $0.14</li>
	<li><a href="https://quotes.benzinga.com/quote/BHHKF" target="_blank">Benchmark Botanics</a>&nbsp;(OTC:<a class="ticker" href="/stock/BHHKF#OTC">BHHKF</a>) shares closed down 5.31% at $0.15</li>
	<li><a href="https://quotes.benzinga.com/quote/HRVSF" target="_blank">Harvest Health</a>&nbsp;(OTCQX:<a class="ticker" href="/stock/HRVSF#OTCQX">HRVSF</a>) shares closed down 4.21% at $1.03</li>
	<li><a href="https://quotes.benzinga.com/quote/CARA" target="_blank">Cara Therapeutics</a>&nbsp;(NASDAQ:<a class="ticker" href="/stock/CARA#NASDAQ">CARA</a>) shares closed down 4.17% at $12.40</li>
	<li><a href="https://quotes.benzinga.com/quote/OGI" target="_blank">OrganiGram Holdings</a>&nbsp;(NASDAQ:<a class="ticker" href="/stock/OGI#NASDAQ">OGI</a>) shares closed down 3.81% at $1.01</li>
</ul>

<a href="https://www.benzinga.com/cannabis/stocks/">Check out a full list of cannabis stock movers in real time following this link.</a>

Lead image by Ilona Szentivanyi. Copyright: Benzinga.

Cannabis Stock Gainers And Losers From September 28, 2020

<h3>GAINERS:</h3>

<ul>
	<li><a href="https://quotes.benzinga.com/quote/SOL" target="_blank">ReneSola</a>&nbsp;(NYSE:<a class="ticker" href="/stock/SOL#NYSE">SOL</a>) shares closed up 23% at $2.62</li>
	<li><a href="https://quotes.benzinga.com/quote/BE" target="_blank">Bloom Energy</a>&nbsp;(NYSE:<a class="ticker" href="/stock/BE#NYSE">BE</a>) shares closed up 10.32% at $19.53</li>
	<li><a href="https://quotes.benzinga.com/quote/NCNNF" target="_blank">48North Cannabis</a>&nbsp;(OTC:<a class="ticker" href="/stock/NCNNF#OTC">NCNNF</a>) shares closed up 6.78% at $0.12</li>
	<li><a href="https://quotes.benzinga.com/quote/DRVD" target="_blank">Driven Deliveries</a>&nbsp;(OTCQB:<a class="ticker" href="/stock/DRVD#OTCQB">DRVD</a>) shares closed up 5.56% at $0.38</li>
	<li><a href="https://quotes.benzinga.com/quote/ACNNF" target="_blank">AusCann Group Holdings</a>&nbsp;(OTCQX:<a class="ticker" href="/stock/ACNNF#OTCQX">ACNNF</a>) shares closed up 5.49% at $0.10</li>
	<li><a href="https://quotes.benzinga.com/quote/LQSIF" target="_blank">Alcanna</a>&nbsp;(OTC:<a class="ticker" href="/stock/LQSIF#OTC">LQSIF</a>) shares closed up 5.22% at $3.39</li>
	<li><a href="https://quotes.benzinga.com/quote/VRNDF" target="_blank">Delta 9 Cannabis</a>&nbsp;(OTCQX:<a class="ticker" href="/stock/VRNDF#OTCQX">VRNDF</a>) shares closed up 5.04% at $0.43</li>
	<li><a href="https://quotes.benzinga.com/quote/HERTF" target="_blank">Heritage Cannabis Holding</a>&nbsp;(OTCQX:<a class="ticker" href="/stock/HERTF#OTCQX">HERTF</a>) shares closed up 4.82% at $0.10</li>
	<li><a href="https://quotes.benzinga.com/quote/NEPT" target="_blank">Neptune Wellness Solns</a>&nbsp;(NASDAQ:<a class="ticker" href="/stock/NEPT#NASDAQ">NEPT</a>) shares closed up 4.76% at $2.20</li>
	<li><a href="https://quotes.benzinga.com/quote/HRVSF" target="_blank">Harvest Health</a>&nbsp;(OTCQX:<a class="ticker" href="/stock/HRVSF#OTCQX">HRVSF</a>) shares closed up 3.91% at $1.20</li>
	<li><a href="https://quotes.benzinga.com/quote/INLB" target="_blank">Item 9 Labs</a>&nbsp;(OTCQX:<a class="ticker" href="/stock/INLB#OTCQX">INLB</a>) shares closed up 3.7% at $1.40</li>
</ul>

<h3>LOSERS:</h3>

<ul>
	<li><a href="https://quotes.benzinga.com/quote/CRBP" target="_blank">Corbus Pharmaceuticals</a>&nbsp;(NASDAQ:<a class="ticker" href="/stock/CRBP#NASDAQ">CRBP</a>) shares closed down 35.98% at $1.21</li>
	<li><a href="https://quotes.benzinga.com/quote/BHHKF" target="_blank">Benchmark Botanics</a>&nbsp;(OTC:<a class="ticker" href="/stock/BHHKF#OTC">BHHKF</a>) shares closed down 29.72% at $0.11</li>
	<li><a href="https://quotes.benzinga.com/quote/ELLXF" target="_blank">Elixinol Global</a>&nbsp;(OTC:<a class="ticker" href="/stock/ELLXF#OTC">ELLXF</a>) shares closed down 16.67% at $0.10</li>
	<li><a href="https://quotes.benzinga.com/quote/AGEEF" target="_blank">Halo Labs</a>&nbsp;(OTCQX:<a class="ticker" href="/stock/AGEEF#OTCQX">AGEEF</a>) shares closed down 16.29% at $0.59</li>
	<li><a href="https://quotes.benzinga.com/quote/CNVCF" target="_blank">BioHarvest Sciences</a>&nbsp;(OTC:<a class="ticker" href="/stock/CNVCF#OTC">CNVCF</a>) shares closed down 11.46% at $0.1</li>
	<li><a href="https://quotes.benzinga.com/quote/TLRY" target="_blank">Tilray</a>&nbsp;(NASDAQ:<a class="ticker" href="/stock/TLRY#NASDAQ">TLRY</a>) shares closed down 9.26% at $4.90</li>
	<li><a href="https://quotes.benzinga.com/quote/CNTMF" target="_blank">Cansortium</a>&nbsp;(OTCQB:<a class="ticker" href="/stock/CNTMF#OTCQB">CNTMF</a>) shares closed down&nbsp;6.63% at $0.28</li>
	<li><a href="https://quotes.benzinga.com/quote/KHRNF" target="_blank">Life Sciences</a>&nbsp;(OTCQX:<a class="ticker" href="/stock/KHRNF#OTCQX">KHRNF</a>) shares closed down&nbsp;6.09% at $0.31</li>
	<li><a href="https://quotes.benzinga.com/quote/BLOZF" target="_blank">Cannabix Technologies</a>&nbsp;(OTC:<a class="ticker" href="/stock/BLOZF#OTC">BLOZF</a>) shares closed down&nbsp;5.87% at $0.31</li>
	<li><a href="https://quotes.benzinga.com/quote/CBWTF" target="_blank">Auxly Cannabis Group</a>&nbsp;(OTCQX:<a class="ticker" href="/stock/CBWTF#OTCQX">CBWTF</a>) shares closed down&nbsp;4.58% at $0.10</li>
	<li><a href="https://quotes.benzinga.com/quote/VFF" target="_blank">Village Farms Intl</a>&nbsp;(NASDAQ:<a class="ticker" href="/stock/VFF#NASDAQ">VFF</a>) shares closed down&nbsp;4.29% at $4.68</li>
	<li><a href="https://quotes.benzinga.com/quote/CGC" target="_blank">Canopy Gwth</a>&nbsp;(NYSE:<a class="ticker" href="/stock/CGC#NYSE">CGC</a>) shares closed down&nbsp;4.12% at $14.32</li>
</ul>

<a href="https://www.benzinga.com/cannabis/stocks/">Check out a full list of cannabis stock movers in real time following this link.</a>

Lead image by Ilona Szentivanyi. Copyright: Benzinga

Cannabis Stock Gainers And Losers From October 6, 2020

<h3>GAINERS:</h3>

<ul>
	<li><a href="https://quotes.benzinga.com/quote/MGCLF" target="_blank">MGC Pharmaceuticals</a>&nbsp;(OTC:<a class="ticker" href="/stock/MGCLF#OTC">MGCLF</a>) shares closed up 100% at $0.02</li>
	<li><a href="https://quotes.benzinga.com/quote/CBWTF" target="_blank">Auxly Cannabis Group</a>&nbsp;(OTCQX:<a class="ticker" href="/stock/CBWTF#OTCQX">CBWTF</a>) shares closed up 24.67% at $0.16</li>
	<li><a href="https://quotes.benzinga.com/quote/XXII" target="_blank">22nd Century Group, Inc. Common Stock</a>&nbsp;(AMEX:<a class="ticker" href="/stock/XXII#AMEX">XXII</a>) shares closed up 11.97% at $0.86</li>
	<li><a href="https://quotes.benzinga.com/quote/LIBFF" target="_blank">Nova Mentis Life Science</a>&nbsp;(OTC:<a class="ticker" href="/stock/LIBFF#OTC">LIBFF</a>) shares closed up 7.8% at $0.15</li>
	<li><a href="https://quotes.benzinga.com/quote/AUSAF" target="_blank">Australis Capital</a>&nbsp;(OTCQB:<a class="ticker" href="/stock/AUSAF#OTCQB">AUSAF</a>) shares closed up 7.05% at $0.12</li>
	<li><a href="https://quotes.benzinga.com/quote/INLB" target="_blank">Item 9 Labs</a>&nbsp;(OTCQX:<a class="ticker" href="/stock/INLB#OTCQX">INLB</a>) shares closed up 5.71% at $1.48</li>
	<li><a href="https://quotes.benzinga.com/quote/CNTMF" target="_blank">Cansortium</a>&nbsp;(OTCQB:<a class="ticker" href="/stock/CNTMF#OTCQB">CNTMF</a>) shares closed up 5.08% at $0.31</li>
	<li><a href="https://quotes.benzinga.com/quote/IMLFF" target="_blank">InMed Pharmaceuticals</a>&nbsp;(OTCQX:<a class="ticker" href="/stock/IMLFF#OTCQX">IMLFF</a>) shares closed up 5.03% at $3.76</li>
	<li><a href="https://quotes.benzinga.com/quote/HERTF" target="_blank">Heritage Cannabis Holding</a>&nbsp;(OTCQX:<a class="ticker" href="/stock/HERTF#OTCQX">HERTF</a>) shares closed up 4.94% at $0.12</li>
	<li><a href="https://quotes.benzinga.com/quote/NINE" target="_blank">Nine Energy Service</a>&nbsp;(NYSE:<a class="ticker" href="/stock/NINE#NYSE">NINE</a>) shares closed up 4.65% at $1.35</li>
	<li><a href="https://quotes.benzinga.com/quote/ACNNF" target="_blank">AusCann Group Holdings</a>&nbsp;(OTCQX:<a class="ticker" href="/stock/ACNNF#OTCQX">ACNNF</a>) shares closed up 4.26% at $0.10</li>
	<li><a href="https://quotes.benzinga.com/quote/ICNAF" target="_blank">Icanic Brands</a>&nbsp;(OTCQB:<a class="ticker" href="/stock/ICNAF#OTCQB">ICNAF</a>) shares closed up 4.09% at $0.28</li>
	<li><a href="https://quotes.benzinga.com/quote/MMNFF" target="_blank">MedMen Enterprises</a>&nbsp;(OTCQX:<a class="ticker" href="/stock/MMNFF#OTCQX">MMNFF</a>) shares closed up 3.91% at $0.16</li>
	<li><a href="https://quotes.benzinga.com/quote/TRSSF" target="_blank">TerrAscend</a>&nbsp;(OTCQX:<a class="ticker" href="/stock/TRSSF#OTCQX">TRSSF</a>) shares closed up 3.65% at $5.80</li>
	<li><a href="https://quotes.benzinga.com/quote/NEXCF" target="_blank">NexTech AR Solns</a>&nbsp;(OTCQB:<a class="ticker" href="/stock/NEXCF#OTCQB">NEXCF</a>) shares closed up 3.28% at $6.33</li>
</ul>

<h3>LOSERS:</h3>

<ul>
	<li><a href="https://quotes.benzinga.com/quote/BHHKF" target="_blank">Benchmark Botanics</a>&nbsp;(OTC:<a class="ticker" href="/stock/BHHKF#OTC">BHHKF</a>) shares closed down 27.27% at $0.11</li>
	<li><a href="https://quotes.benzinga.com/quote/FLOOF" target="_blank">Flower One Hldgs</a>&nbsp;(OTCQX:<a class="ticker" href="/stock/FLOOF#OTCQX">FLOOF</a>) shares closed down 11.45% at $0.15</li>
	<li><a href="https://quotes.benzinga.com/quote/CNGGF" target="_blank">Cann Gr</a>&nbsp;(OTC:<a class="ticker" href="/stock/CNGGF#OTC">CNGGF</a>) shares closed down 9.38% at $0.29</li>
	<li><a href="https://quotes.benzinga.com/quote/NEPT" target="_blank">Neptune Wellness Solns</a>&nbsp;(NASDAQ:<a class="ticker" href="/stock/NEPT#NASDAQ">NEPT</a>) shares closed down 8.79% at $2.18</li>
	<li><a href="https://quotes.benzinga.com/quote/CBIIF" target="_blank">CB2 Insights</a>&nbsp;(OTCQB:<a class="ticker" href="/stock/CBIIF#OTCQB">CBIIF</a>) shares closed down 8.09% at $0.29</li>
	<li><a href="https://quotes.benzinga.com/quote/HITIF" target="_blank">High Tide</a>&nbsp;(OTCQB:<a class="ticker" href="/stock/HITIF#OTCQB">HITIF</a>) shares closed down 5.94% at $0.12</li>
	<li><a href="https://quotes.benzinga.com/quote/OGI" target="_blank">OrganiGram Holdings</a>&nbsp;(NASDAQ:<a class="ticker" href="/stock/OGI#NASDAQ">OGI</a>) shares closed down 5.51% at $1.20</li>
	<li><a href="https://quotes.benzinga.com/quote/GRWG" target="_blank">GrowGeneration</a>&nbsp;(NASDAQ:<a class="ticker" href="/stock/GRWG#NASDAQ">GRWG</a>) shares closed down 5.27% at $17.44</li>
	<li><a href="https://quotes.benzinga.com/quote/ACB" target="_blank">Aurora Cannabis</a>&nbsp;(NYSE:<a class="ticker" href="/stock/ACB#NYSE">ACB</a>) shares closed down 4.71% at $4.55</li>
</ul>

<a href="https://www.benzinga.com/cannabis/stocks/">Check out a full list of cannabis stock movers in real time following this link.</a>

Lead image by Ilona Szentivanyi. Copyright: Benzinga.

Cannabis Stock Gainers And Losers From October 14, 2020

<h3>GAINERS:</h3>

<ul>
	<li><a href="https://quotes.benzinga.com/quote/HLIX" target="_blank">Helix TCS</a>&nbsp;(OTCQB:<a class="ticker" href="/stock/HLIX#OTCQB">HLIX</a>) shares closed up 232.82% at $0.33</li>
	<li><a href="https://quotes.benzinga.com/quote/BHHKF" target="_blank">Benchmark Botanics</a>&nbsp;(OTC:<a class="ticker" href="/stock/BHHKF#OTC">BHHKF</a>) shares closed up 41.52% at $0.15</li>
	<li><a href="https://quotes.benzinga.com/quote/ACB" target="_blank">Aurora Cannabis</a>&nbsp;(NYSE:<a class="ticker" href="/stock/ACB#NYSE">ACB</a>) shares closed up 16.63% at $4.70</li>
	<li><a href="https://quotes.benzinga.com/quote/TLRY" target="_blank">Tilray</a>&nbsp;(NASDAQ:<a class="ticker" href="/stock/TLRY#NASDAQ">TLRY</a>) shares closed up 16.55% at $6.48</li>
	<li><a href="https://quotes.benzinga.com/quote/NWVCF" target="_blank">EnWave</a>&nbsp;(OTC:<a class="ticker" href="/stock/NWVCF#OTC">NWVCF</a>) shares closed up 13.83% at $0.76</li>
	<li><a href="https://quotes.benzinga.com/quote/CBWTF" target="_blank">Auxly Cannabis Group</a>&nbsp;(OTCQX:<a class="ticker" href="/stock/CBWTF#OTCQX">CBWTF</a>) shares closed up 12.73% at $0.25</li>
	<li><a href="https://quotes.benzinga.com/quote/ICNAF" target="_blank">Icanic Brands</a>&nbsp;(OTCQB:<a class="ticker" href="/stock/ICNAF#OTCQB">ICNAF</a>) shares closed up 12.69% at $0.33</li>
	<li><a href="https://quotes.benzinga.com/quote/CGC" target="_blank">Canopy Gwth</a>&nbsp;(NYSE:<a class="ticker" href="/stock/CGC#NYSE">CGC</a>) shares closed up 11.66% at $19.82</li>
	<li><a href="https://quotes.benzinga.com/quote/CNVCF" target="_blank">BioHarvest Sciences</a>&nbsp;(OTC:<a class="ticker" href="/stock/CNVCF#OTC">CNVCF</a>) shares closed up 10.09% at $0.11</li>
	<li><a href="https://quotes.benzinga.com/quote/ELLXF" target="_blank">Elixinol Global</a>&nbsp;(OTC:<a class="ticker" href="/stock/ELLXF#OTC">ELLXF</a>) shares closed up 8.18% at $0.12</li>
	<li><a href="https://quotes.benzinga.com/quote/ACNNF" target="_blank">AusCann Group Holdings</a>&nbsp;(OTCQX:<a class="ticker" href="/stock/ACNNF#OTCQX">ACNNF</a>) shares closed up 7.2% at $0.10</li>
	<li><a href="https://quotes.benzinga.com/quote/LQSIF" target="_blank">Alcanna</a>&nbsp;(OTC:<a class="ticker" href="/stock/LQSIF#OTC">LQSIF</a>) shares closed up 6.42% at $3.97</li>
	<li><a href="https://quotes.benzinga.com/quote/OGI" target="_blank">OrganiGram Holdings</a>&nbsp;(NASDAQ:<a class="ticker" href="/stock/OGI#NASDAQ">OGI</a>) shares closed up 5.93% at $1.25</li>
	<li><a href="https://quotes.benzinga.com/quote/CRON" target="_blank">Cronos Group</a>&nbsp;(NASDAQ:<a class="ticker" href="/stock/CRON#NASDAQ">CRON</a>) shares closed up 5.89% at $5.75</li>
	<li><a href="https://quotes.benzinga.com/quote/GRWG" target="_blank">GrowGeneration</a>&nbsp;(NASDAQ:<a class="ticker" href="/stock/GRWG#NASDAQ">GRWG</a>) shares closed up 5.69% at $18.38</li>
	<li><a href="https://quotes.benzinga.com/quote/GNLN" target="_blank">Greenlane Holdings</a>&nbsp;(NASDAQ:<a class="ticker" href="/stock/GNLN#NASDAQ">GNLN</a>) shares closed up 5.25% at $3.01</li>
	<li><a href="https://quotes.benzinga.com/quote/XXII" target="_blank">22nd Century Group, Inc. Common Stock</a>&nbsp;(AMEX:<a class="ticker" href="/stock/XXII#AMEX">XXII</a>) shares closed up 4.67% at $0.89</li>
	<li><a href="https://quotes.benzinga.com/quote/CURLF" target="_blank">Curaleaf Holdings</a>&nbsp;(OTCQX:<a class="ticker" href="/stock/CURLF#OTCQX">CURLF</a>) shares closed up 3.7% at $9.07</li>
</ul>

<h3>LOSERS:</h3>

<ul>
	<li><a href="https://quotes.benzinga.com/quote/HERTF" target="_blank">Heritage Cannabis Holding</a>&nbsp;(OTCQX:<a class="ticker" href="/stock/HERTF#OTCQX">HERTF</a>) shares closed down 14.58% at $0.10</li>
	<li><a href="https://quotes.benzinga.com/quote/INLB" target="_blank">Item 9 Labs</a>&nbsp;(OTCQX:<a class="ticker" href="/stock/INLB#OTCQX">INLB</a>) shares closed down 11.72% at $1.28</li>
	<li><a href="https://quotes.benzinga.com/quote/NINE" target="_blank">Nine Energy Service</a>&nbsp;(NYSE:<a class="ticker" href="/stock/NINE#NYSE">NINE</a>) shares closed down 10.58% at $1.14</li>
	<li><a href="https://quotes.benzinga.com/quote/CURR" target="_blank">CURE Pharmaceutical Hldg</a>&nbsp;(OTCQB:<a class="ticker" href="/stock/CURR#OTCQB">CURR</a>) shares closed down 10.17% at $1.06</li>
	<li><a href="https://quotes.benzinga.com/quote/CRBP" target="_blank">Corbus Pharmaceuticals</a>&nbsp;(NASDAQ:<a class="ticker" href="/stock/CRBP#NASDAQ">CRBP</a>) shares closed down 8.11% at $1.02</li>
	<li><a href="https://quotes.benzinga.com/quote/GRIN" target="_blank">Grindrod Shipping Hldgs</a>&nbsp;(NASDAQ:<a class="ticker" href="/stock/GRIN#NASDAQ">GRIN</a>) shares closed down 4.75% at $3.81</li>
	<li><a href="https://quotes.benzinga.com/quote/ARNA" target="_blank">Arena Pharmaceuticals</a>&nbsp;(NASDAQ:<a class="ticker" href="/stock/ARNA#NASDAQ">ARNA</a>) shares closed down 4.18% at $77.54</li>
	<li><a href="https://quotes.benzinga.com/quote/GHG" target="_blank">GreenTree Hospitality Gr</a>&nbsp;(NYSE:<a class="ticker" href="/stock/GHG#NYSE">GHG</a>) shares closed down 4.1% at $13.33</li>
</ul>

<a href="https://www.benzinga.com/cannabis/stocks/">Check out a full list of cannabis stock movers in real time following this link.</a>

Lead image by Ilona Szentivanyi. Copyright: Benzinga.

Cannabis Stock Gainers And Losers From October 19, 2020

<h3>GAINERS:</h3>

<ul>
	<li><a href="https://quotes.benzinga.com/quote/VREOF" target="_blank">Vireo Health Intl</a>&nbsp;(OTCQX:<a class="ticker" href="/stock/VREOF#OTCQX">VREOF</a>) shares closed up 19.23% at $1.03</li>
	<li><a href="https://quotes.benzinga.com/quote/GRIN" target="_blank">Grindrod Shipping Hldgs</a>&nbsp;(NASDAQ:<a class="ticker" href="/stock/GRIN#NASDAQ">GRIN</a>) shares closed up 18.36% at $3.84</li>
	<li><a href="https://quotes.benzinga.com/quote/CURR" target="_blank">CURE Pharmaceutical Hldg</a>&nbsp;(OTCQB:<a class="ticker" href="/stock/CURR#OTCQB">CURR</a>) shares closed up 13.64% at $1.25</li>
	<li><a href="https://quotes.benzinga.com/quote/TBPMF" target="_blank">Tetra Bio Pharma</a>&nbsp;(OTCQB:<a class="ticker" href="/stock/TBPMF#OTCQB">TBPMF</a>) shares closed up 13.28% at $0.13</li>
	<li><a href="https://quotes.benzinga.com/quote/ZLDAF" target="_blank">Zelira Therapeutics</a>&nbsp;(OTCQB:<a class="ticker" href="/stock/ZLDAF#OTCQB">ZLDAF</a>) shares closed up 10.71% at $0.06</li>
	<li><a href="https://quotes.benzinga.com/quote/HRVSF" target="_blank">Harvest Health</a>&nbsp;(OTCQX:<a class="ticker" href="/stock/HRVSF#OTCQX">HRVSF</a>) shares closed up 9.29% at $1.53</li>
	<li><a href="https://quotes.benzinga.com/quote/INLB" target="_blank">Item 9 Labs</a>&nbsp;(OTCQX:<a class="ticker" href="/stock/INLB#OTCQX">INLB</a>) shares closed up 9.09% at $1.20</li>
	<li><a href="https://quotes.benzinga.com/quote/CURLF" target="_blank">Curaleaf Holdings</a>&nbsp;(OTCQX:<a class="ticker" href="/stock/CURLF#OTCQX">CURLF</a>) shares closed up 8.03% at $9.28</li>
	<li><a href="https://quotes.benzinga.com/quote/CXXIF" target="_blank">C21 Investments</a>&nbsp;(OTCQX:<a class="ticker" href="/stock/CXXIF#OTCQX">CXXIF</a>) shares closed up 7.65% at $0.60</li>
	<li><a href="https://quotes.benzinga.com/quote/ACB" target="_blank">Aurora Cannabis</a>&nbsp;(NYSE:<a class="ticker" href="/stock/ACB#NYSE">ACB</a>) shares closed up 6.8% at $4.09</li>
	<li><a href="https://quotes.benzinga.com/quote/FFNTF" target="_blank">4Front Ventures</a>&nbsp;(OTCQX:<a class="ticker" href="/stock/FFNTF#OTCQX">FFNTF</a>) shares closed up 6.52% at $0.63</li>
	<li><a href="https://quotes.benzinga.com/quote/NEPT" target="_blank">Neptune Wellness Solns</a>&nbsp;(NASDAQ:<a class="ticker" href="/stock/NEPT#NASDAQ">NEPT</a>) shares closed up 6.11% at $1.91</li>
	<li><a href="https://quotes.benzinga.com/quote/TLRY" target="_blank">Tilray</a>&nbsp;(NASDAQ:<a class="ticker" href="/stock/TLRY#NASDAQ">TLRY</a>) shares closed up 5.66% at $5.97</li>
	<li><a href="https://quotes.benzinga.com/quote/GTBIF" target="_blank">Green Thumb Industries</a>&nbsp;(OTCQX:<a class="ticker" href="/stock/GTBIF#OTCQX">GTBIF</a>) shares closed up 4.47% at $15.67</li>
	<li><a href="https://quotes.benzinga.com/quote/XXII" target="_blank">22nd Century Group, Inc. Common Stock</a>&nbsp;(AMEX:<a class="ticker" href="/stock/XXII#AMEX">XXII</a>) shares closed up 4.46% at $0.73</li>
	<li><a href="https://quotes.benzinga.com/quote/GRWG" target="_blank">GrowGeneration</a>&nbsp;(NASDAQ:<a class="ticker" href="/stock/GRWG#NASDAQ">GRWG</a>) shares closed up 4.12% at $17.18</li>
	<li><a href="https://quotes.benzinga.com/quote/TER" target="_blank">Teradyne</a>&nbsp;(NASDAQ:<a class="ticker" href="/stock/TER#NASDAQ">TER</a>) shares closed up 3.51% at $88.54</li>
</ul>

<h3>LOSERS:</h3>

<ul>
	<li><a href="https://quotes.benzinga.com/quote/BHHKF" target="_blank">Benchmark Botanics</a>&nbsp;(OTC:<a class="ticker" href="/stock/BHHKF#OTC">BHHKF</a>) shares closed down 29.52% at $0.11</li>
	<li><a href="https://quotes.benzinga.com/quote/LIBFF" target="_blank">Nova Mentis Life Science</a>&nbsp;(OTC:<a class="ticker" href="/stock/LIBFF#OTC">LIBFF</a>) shares closed down 12.7% at $0.13</li>
	<li><a href="https://quotes.benzinga.com/quote/CNGGF" target="_blank">Cann Gr</a>&nbsp;(OTC:<a class="ticker" href="/stock/CNGGF#OTC">CNGGF</a>) shares closed down 11.54% at $0.23</li>
	<li><a href="https://quotes.benzinga.com/quote/BLOZF" target="_blank">Cannabix Technologies</a>&nbsp;(OTC:<a class="ticker" href="/stock/BLOZF#OTC">BLOZF</a>) shares closed down 7.7% at $0.33</li>
	<li><a href="https://quotes.benzinga.com/quote/NWVCF" target="_blank">EnWave</a>&nbsp;(OTC:<a class="ticker" href="/stock/NWVCF#OTC">NWVCF</a>) shares closed down 5.05% at $0.67</li>
	<li><a href="https://quotes.benzinga.com/quote/NXGWF" target="_blank">Next Green Wave Holdings</a>&nbsp;(OTCQX:<a class="ticker" href="/stock/NXGWF#OTCQX">NXGWF</a>) shares closed down 4.8% at $0.30</li>
	<li><a href="https://quotes.benzinga.com/quote/GENE" target="_blank">Genetic Technologies</a>&nbsp;(NASDAQ:<a class="ticker" href="/stock/GENE#NASDAQ">GENE</a>) shares closed down 4.08% at $3.06</li>
	<li><a href="https://quotes.benzinga.com/quote/NEXCF" target="_blank">NexTech AR Solns</a>&nbsp;(OTCQB:<a class="ticker" href="/stock/NEXCF#OTCQB">NEXCF</a>) shares closed down 3.03% at $5.34</li>
	<li><a href="https://quotes.benzinga.com/quote/WRLD" target="_blank">World Acceptance</a>&nbsp;(NASDAQ:<a class="ticker" href="/stock/WRLD#NASDAQ">WRLD</a>) shares closed down 2.36% at $87.58</li>
	<li><a href="https://quotes.benzinga.com/quote/VIVO" target="_blank">Meridian Bioscience</a>&nbsp;(NASDAQ:<a class="ticker" href="/stock/VIVO#NASDAQ">VIVO</a>) shares closed down 1.77% at $19.41</li>
</ul>

<a href="https://www.benzinga.com/cannabis/stocks/">Check out a full list of cannabis stock movers in real time following this link.</a>

Lead image by Ilona Szentivanyi. Copyright: Benzinga.

Cannabis Stock Gainers And Losers From October 29, 2020

<h3>GAINERS:</h3>

<ul>
	<li><a href="https://quotes.benzinga.com/quote/LIBFF" target="_blank">Nova Mentis Life Science</a>&nbsp;(OTC:<a class="ticker" href="/stock/LIBFF#OTC">LIBFF</a>) shares closed up 21.74% at $0.15</li>
	<li><a href="https://quotes.benzinga.com/quote/BHHKF" target="_blank">Benchmark Botanics</a>&nbsp;(OTC:<a class="ticker" href="/stock/BHHKF#OTC">BHHKF</a>) shares closed up 21.41% at $0.13</li>
	<li><a href="https://quotes.benzinga.com/quote/HRVSF" target="_blank">Harvest Health</a>&nbsp;(OTCQX:<a class="ticker" href="/stock/HRVSF#OTCQX">HRVSF</a>) shares closed up 18.47% at $1.81</li>
	<li><a href="https://quotes.benzinga.com/quote/ACB" target="_blank">Aurora Cannabis</a>&nbsp;(NYSE:<a class="ticker" href="/stock/ACB#NYSE">ACB</a>) shares closed up 16.81% at $4.73</li>
	<li><a href="https://quotes.benzinga.com/quote/TLRY" target="_blank">Tilray</a>&nbsp;(NASDAQ:<a class="ticker" href="/stock/TLRY#NASDAQ">TLRY</a>) shares closed up 16.64% at $6.66</li>
	<li><a href="https://quotes.benzinga.com/quote/INLB" target="_blank">Item 9 Labs</a>&nbsp;(OTCQX:<a class="ticker" href="/stock/INLB#OTCQX">INLB</a>) shares closed up 16% at $1.45</li>
	<li><a href="https://quotes.benzinga.com/quote/CRON" target="_blank">Cronos Group</a>&nbsp;(NASDAQ:<a class="ticker" href="/stock/CRON#NASDAQ">CRON</a>) shares closed up 13.61% at $6.01</li>
	<li><a href="https://quotes.benzinga.com/quote/IMLFF" target="_blank">InMed Pharmaceuticals</a>&nbsp;(OTCQX:<a class="ticker" href="/stock/IMLFF#OTCQX">IMLFF</a>) shares closed up 12.8% at $3.76</li>
	<li><a href="https://quotes.benzinga.com/quote/CXXIF" target="_blank">C21 Investments</a>&nbsp;(OTCQX:<a class="ticker" href="/stock/CXXIF#OTCQX">CXXIF</a>) shares closed up 12.26% at $0.64</li>
	<li><a href="https://quotes.benzinga.com/quote/CNVCF" target="_blank">BioHarvest Sciences</a>&nbsp;(OTC:<a class="ticker" href="/stock/CNVCF#OTC">CNVCF</a>) shares closed up 12.22% at $0.10</li>
	<li><a href="https://quotes.benzinga.com/quote/CGC" target="_blank">Canopy Gwth</a>&nbsp;(NYSE:<a class="ticker" href="/stock/CGC#NYSE">CGC</a>) shares closed up 11.98% at $21.03</li>
	<li><a href="https://quotes.benzinga.com/quote/APHA" target="_blank">Aphria</a>&nbsp;(NASDAQ:<a class="ticker" href="/stock/APHA#NASDAQ">APHA</a>) shares closed up 11.78% at $5.03</li>
	<li><a href="https://quotes.benzinga.com/quote/SOL" target="_blank">ReneSola</a>&nbsp;(NYSE:<a class="ticker" href="/stock/SOL#NYSE">SOL</a>) shares closed up 11.61% at $3.46</li>
	<li><a href="https://quotes.benzinga.com/quote/VFF" target="_blank">Village Farms Intl</a>&nbsp;(NASDAQ:<a class="ticker" href="/stock/VFF#NASDAQ">VFF</a>) shares closed up 11.4% at $5.18</li>
	<li><a href="https://quotes.benzinga.com/quote/CWBHF" target="_blank">Charlottes Web Holdings</a>&nbsp;(OTCQX:<a class="ticker" href="/stock/CWBHF#OTCQX">CWBHF</a>) shares closed up 11.37% at $3.09</li>
	<li><a href="https://quotes.benzinga.com/quote/GRWG" target="_blank">GrowGeneration</a>&nbsp;(NASDAQ:<a class="ticker" href="/stock/GRWG#NASDAQ">GRWG</a>) shares closed up 11.02% at $18.54</li>
	<li><a href="https://quotes.benzinga.com/quote/GNLN" target="_blank">Greenlane Holdings</a>&nbsp;(NASDAQ:<a class="ticker" href="/stock/GNLN#NASDAQ">GNLN</a>) shares closed up 10.7% at $2.69</li>
	<li><a href="https://quotes.benzinga.com/quote/TRSSF" target="_blank">TerrAscend</a>&nbsp;(OTCQX:<a class="ticker" href="/stock/TRSSF#OTCQX">TRSSF</a>) shares closed up 10.54% at $6.40</li>
	<li><a href="https://quotes.benzinga.com/quote/OGI" target="_blank">OrganiGram Holdings</a>&nbsp;(NASDAQ:<a class="ticker" href="/stock/OGI#NASDAQ">OGI</a>) shares closed up 10% at $1.32</li>
	<li><a href="https://quotes.benzinga.com/quote/CRLBF" target="_blank">Cresco Labs</a>&nbsp;(OTCQX:<a class="ticker" href="/stock/CRLBF#OTCQX">CRLBF</a>) shares closed up 9.07% at $7.70</li>
	<li><a href="https://quotes.benzinga.com/quote/HEXO" target="_blank">HEXO</a>&nbsp;(NYSE:<a class="ticker" href="/stock/HEXO#NYSE">HEXO</a>) shares closed up 7.65% at $0.65</li>
	<li><a href="https://quotes.benzinga.com/quote/CNTMF" target="_blank">Cansortium</a>&nbsp;(OTCQB:<a class="ticker" href="/stock/CNTMF#OTCQB">CNTMF</a>) shares closed up 7.14% at $0.30</li>
	<li><a href="https://quotes.benzinga.com/quote/CURLF" target="_blank">Curaleaf Holdings</a>&nbsp;(OTCQX:<a class="ticker" href="/stock/CURLF#OTCQX">CURLF</a>) shares closed up 7.01% at $10.04</li>
	<li><a href="https://quotes.benzinga.com/quote/GTBIF" target="_blank">Green Thumb Industries</a>&nbsp;(OTCQX:<a class="ticker" href="/stock/GTBIF#OTCQX">GTBIF</a>) shares closed up 6.1% at $16.70</li>
	<li><a href="https://quotes.benzinga.com/quote/IIPR" target="_blank">Innovative Industrial</a>&nbsp;(NYSE:<a class="ticker" href="/stock/IIPR#NYSE">IIPR</a>) shares closed up 5.15% at $122.42</li>
	<li><a href="https://quotes.benzinga.com/quote/SMG" target="_blank">The Scotts Miracle Gro</a>&nbsp;(NYSE:<a class="ticker" href="/stock/SMG#NYSE">SMG</a>) shares closed up 3.64% at $155.37</li>
</ul>

<h3>LOSERS:</h3>

<ul>
	<li><a href="https://quotes.benzinga.com/quote/ZLDAF" target="_blank">Zelira Therapeutics</a>&nbsp;(OTCQB:<a class="ticker" href="/stock/ZLDAF#OTCQB">ZLDAF</a>) shares closed down 10.67% at $0.05</li>
	<li><a href="https://quotes.benzinga.com/quote/CNGGF" target="_blank">Cann Gr</a>&nbsp;(OTC:<a class="ticker" href="/stock/CNGGF#OTC">CNGGF</a>) shares closed down 8.7% at $0.21</li>
	<li><a href="https://quotes.benzinga.com/quote/NXGWF" target="_blank">Next Green Wave Holdings</a>&nbsp;(OTCQX:<a class="ticker" href="/stock/NXGWF#OTCQX">NXGWF</a>) shares closed down 8.28% at $0.27</li>
	<li><a href="https://quotes.benzinga.com/quote/NEPT" target="_blank">Neptune Wellness Solns</a>&nbsp;(NASDAQ:<a class="ticker" href="/stock/NEPT#NASDAQ">NEPT</a>) shares closed down 7.25% at $1.79</li>
	<li><a href="https://quotes.benzinga.com/quote/CNBX" target="_blank">Cannabics Pharmaceuticals</a>&nbsp;(OTCQB:<a class="ticker" href="/stock/CNBX#OTCQB">CNBX</a>) shares closed down 7.19% at $0.18</li>
	<li><a href="https://quotes.benzinga.com/quote/HLIX" target="_blank">Helix TCS</a>&nbsp;(OTCQB:<a class="ticker" href="/stock/HLIX#OTCQB">HLIX</a>) shares closed down 5.75% at $0.17</li>
	<li><a href="https://quotes.benzinga.com/quote/VVCIF" target="_blank">VIVO Cannabis</a>&nbsp;(OTCQX:<a class="ticker" href="/stock/VVCIF#OTCQX">VVCIF</a>) shares closed down 5.68% at $0.09</li>
	<li><a href="https://quotes.benzinga.com/quote/CARA" target="_blank">Cara Therapeutics</a>&nbsp;(NASDAQ:<a class="ticker" href="/stock/CARA#NASDAQ">CARA</a>) shares closed down 4.07% at $12.72</li>
	<li><a href="https://quotes.benzinga.com/quote/ARNA" target="_blank">Arena Pharmaceuticals</a>&nbsp;(NASDAQ:<a class="ticker" href="/stock/ARNA#NASDAQ">ARNA</a>) shares closed down 3.66% at $82.58</li>
</ul>

<a href="https://www.benzinga.com/cannabis/stocks/">Check out a full list of cannabis stock movers in real time following this link.</a>

Lead image by Ilona Szentivanyi. Copyright: Benzinga.

Recent Quotes

Related Companies

Benchmark Botanics Frequently Asked Questions

How do I buy Benchmark Botanics (BHHKF) stock?

Who are Benchmark Botanics's (BHHKF) competitors?

What is the target price for Benchmark Botanics (BHHKF) stock?

Current Stock Price for Benchmark Botanics (BHHKF)?

Does Benchmark Botanics (BHHKF) pay a dividend?

When is Benchmark Botanics (OTC:BHHKF) reporting earnings?

Is Benchmark Botanics (BHHKF) going to split?

What sector and industry does Benchmark Botanics (BHHKF) operate in?